EP2231028A2 - Procédés et dispositifs de traitement d'un c ur - Google Patents

Procédés et dispositifs de traitement d'un c ur

Info

Publication number
EP2231028A2
EP2231028A2 EP08864599A EP08864599A EP2231028A2 EP 2231028 A2 EP2231028 A2 EP 2231028A2 EP 08864599 A EP08864599 A EP 08864599A EP 08864599 A EP08864599 A EP 08864599A EP 2231028 A2 EP2231028 A2 EP 2231028A2
Authority
EP
European Patent Office
Prior art keywords
anchor
heart
tensioning member
tensioning element
guide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP08864599A
Other languages
German (de)
English (en)
Inventor
Amnon Zlotnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mor Research Applications Ltd
Original Assignee
Mor Research Applications Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mor Research Applications Ltd filed Critical Mor Research Applications Ltd
Publication of EP2231028A2 publication Critical patent/EP2231028A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2451—Inserts in the coronary sinus for correcting the valve shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2478—Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
    • A61F2/2487—Devices within the heart chamber, e.g. splints
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238—Type of minimally invasive operation
    • A61B2017/00243—Type of minimally invasive operation cardiac
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0409—Instruments for applying suture anchors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/048—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery for reducing heart wall tension, e.g. sutures with a pad on each extremity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
    • A61F2/2457—Chordae tendineae prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466—Delivery devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2478—Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
    • A61F2/2481—Devices outside the heart wall, e.g. bags, strips or bands

Definitions

  • the present invention in some embodiments thereof, relates to the field of surgery and Cardiology and in some embodiments to methods, devices and kits potentially useful, for example, for applying force to at least a portion of a mammalian heart, for example to change the shape of the left ventricular cavity, to support a sagging cardiac wall (e.g., caused by remodeling); to improve mitral valve leaflet coaptation and/or to prevent and/or ameliorate mitral valve insufficiency and/or heart failure, to assist contractility of sagging cardiac wall.
  • Some embodiments of the present invention allow, for example, improving mitral leaflet coaptation, for example in order to treat ischemic mitral regurgitation.
  • the surgery is carried out using minimally invasive methods and/or tools.
  • the procedure is carried out using percutaneous catheterization tools.
  • a typical human heart 10 depicted in cross sectional long axis view in Figure 1 , is a muscular organ that pumps deoxygenated blood through the lungs to oxygenate the blood and pumps the oxygenated blood to the rest of the body by rhythmic contractions of four chambers.
  • deoxygenated blood from the body enters the right atrium 12 through the vena cava 14.
  • Right atrium 12 contracts, pumping the blood through a tricuspid valve 16 into the right ventricle 18.
  • Right ventricle 18 contracts, pumping the blood through the pulmonary valve 20 into the pulmonary artery 22 which divides into two branches, one for each lung.
  • the blood is oxygenated while passing through the lungs and reenters the heart to the left atrium 24.
  • Left atrium 24 contracts, pumping the oxygenated blood through the mitral valve 26 into the left ventricle 28.
  • Left ventricle 28 contracts, pumping the oxygenated blood through the aortic valve 30 into the aorta 32. From aorta 32, the oxygenated blood is distributed to the rest of the body.
  • Mitral valve 26 depicted in Figure 2A (top view) and in Figure 2B (cross sectional long axis view) is defined by an approximately circular mitral annulus 34 that defines a mitral valve orifice 36. Attached to the periphery of mitral annulus 34 is an anterior leaflet 38 and a smaller posterior leaflet 40, leaflets 38 and 40 joined at commissures 41.
  • the typical area of mitral valve orifice 36 in a healthy adult is between 4 and 6 cm 2 while the typical total surface area of leaflets 38 and 40 is approximately 12 cm 2 . Consequently and as depicted in Figure 2B, during ventricular systole leaflets 38 and 40 curve downwards into left ventricle 28 and coapt to accommodate the excess leaflet surface area, producing a coaptation surface 42 that constitutes a seal.
  • the typical depth of coaptation surface 42 in a healthy heart 10 of an adult is approximately 7-8 mm.
  • Anterior leaflet 38 and posterior leaflet 40 are connected to papillary muscles 44 of left ventricle 28 by chordae 46.
  • left atrium 24 contracts to pump blood into left ventricle 28 through mitral valve 26.
  • the blood flows through mitral valve orifice 36, pushing leaflets 38 and 40 into left ventricle 28 with little resistance.
  • left ventricle 28 contracts to pump blood into aorta 32 through aortic valve 30.
  • Mitral annulus 34 contracts pushing leaflets 38 and 40 inwards and downwards, reducing the area of mitral valve orifice 36 by about 20% to 30% and increasing the depth of coaptation surface 42.
  • the pressure of blood in left ventricle 28 pushes against the ventricular surfaces of leaflets 38 and 40, tightly pressing leaflets 38 and 40 together at coaptation surface 42 so that a tight leak-proof seal is formed.
  • papillary muscles 44 contract, pulling the edges and body of leaflets
  • mitral valve 26 An effective seal of mitral valve 26 is dependent on a sufficient degree of coaptation, in terms of depth, area and continuity of coaptation surface 42. If coaptation surface 42 is insufficient or non-existent, there is mitral valve insufficiency, that is, regurgitation of blood from left ventricle 28 into left atrium 24. Mitral valve insufficiency leads to many complications including arrhythmia, atrial fibrillation, cardiac palpitations, chest pain, congestive heart failure, fainting, fatigue, low cardiac output, orthopnea, paroxysmal nocturnal dyspnea, pulmonary edema, shortness of breath, and sudden death.
  • chordae 46 e.g., elongated or ruptured chordae 46, weak papillary muscles 44
  • prevent coaptation e.g., short chordae 46, small leaflets 38 and 40.
  • ischemic mitral regurgitation resulting, e.g., from myocardial ischemia or infarction
  • other myocardial disease e.g. Dilated cardiomyopathy
  • leaflets 38 and 40 and chordae 46 have normal structure and the mitral valve insufficiency results from altered geometry of left ventricle 28.
  • ischemia portions of the heart walls necrose.
  • the necrotic tissue is replaced with disorganized tissue leading to remodeling of the heart which reduces coaptation through distortion/dilation of mitral annulus 34 and outwards sagging of the outer wall of left ventricle 28 which displaces papillary muscles 44.
  • FIGs 3A (top view) and 3B (cross sectional long axis view) the reduction of coaptation and incomplete closure of a mitral valve 26 during ventricular systole resulting from ischemia is depicted for an ischemic heart 50 that has undergone remodeling and suffers from ischemic mitral regurgitation.
  • Figure 3B is shown how a wall of left ventricle 28 sags outwards, distorting mitral annulus 34 and displacing papillary muscles 44 outwards which, through chordae 46, pulls leaflets 38 and 40 apart and into left ventricle 28, reducing coaptation.
  • ischemic mitral regurgitation is a minor problem, typically leading only to shortness of breath during physical exercise due to the fact that a small fraction of blood pumped by left ventricle 28 is pumped into left atrium 24 and not through aortic valve 30, reducing heart capacity. To compensate for the reduced capacity, left ventricle 28 contracts harder and remodeling continues. Ultimately leaflet coaptation is nonexistent as leaflets 38 and
  • mammals that suffer from mitral valve insufficiency include horses, cats, dogs, cows, sheep and pigs.
  • United States Patent 6,332,893 describes valve to myocardium tension members. It has been proposed to change the shape of a left ventricle 28 and/or to support the walls of a left ventricle 28 to improve the functioning of a mitral valve 26, see for example, the U.S. Patent Application published as US 2006/0281968, U.S. Patent No. 7,238,152 (as well as products of Paracor Medical, Inc., Sunnyvale, CA, USA) and U.S. Patents Nos. 6,077,214, 6,332,893 and 6,723,038 (as well as products of Myocor, Inc., Maple Grove, MN, USA such as Coapsys®).
  • RING plus STRING Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation
  • Langer, F and Schafers, H-J in J Thorac Cardiovasc Surg 2007; 133; 247-249 is taught implantation of an undersized annuloplasty ring together with deployment of a suture passing through the left ventricle 28 from the head of the posterior papillary muscle 44 to the midseptal fibrous annulus through the aortic wall underneath the commissures of two aortic valve 30 leaflets. While the heart beats and under observation of an imaging device, the suture is tensioned so as to pull the papillary muscle 44 towards the aortic wall until a desired degree of mitral valve leaflet coaptation is observed. The method leads to an increased tension applied to papillary muscle 44, which may stretch and elongate, affecting the angle at which papillary muscle 44 pulls leaflet 38.
  • Some embodiments of the present invention provide methods, devices and kits useful for applying pressure to at least a portion of a mammalian heart, for example to the left ventricle.
  • the applied pressure has a beneficial effect, for example, changing the shape of a left ventricle and/or improving coaptation of mitral valve leaflets and/or supporting sagging portions of the cardiac walls and/or assisting heart contractility and/or relieving/redistributing pressure inside the heart.
  • apparatus for treating a heart comprising: a delivery tube sized for and adapted for insertion into a body; a sharp tip adapted to be pushed through cardiac muscle; an elongate tensioning element; and at least one anchor on said elongate tensioning element and adapted to couple said elongate tension element to cardiac muscle tissue, wherein said delivery tube encloses one or both of said element and said at least one anchor.
  • said sharp tip is formed on an end of said delivery tube.
  • said delivery tube is smooth enough to slide through said cardiac muscle after penetration of said cardiac muscle by said sharp tip.
  • the apparatus comprises a second anchor, mounted on said elongate tensioning element and configured to anchor said elongate tensioning element to different cardiac muscle tissue at a spaced apart position from said at least one anchor.
  • said at least one anchor and said second anchor are configured to be urged against opposite parts of said hearts by said elongate tensioning element.
  • said at least one anchor and said second anchor are adapted to not engage said heart absent tension from said elongate tensioning element.
  • one or both of said at least one anchor and said second anchor are adapted to be axially moved along said elongate tensioning element.
  • one or both of said at least one anchor and said second anchor includes a locking mechanism for selectively locking at a desired position along said elongate tensioning element.
  • said tube is flexible enough to pass through a venous system to the heart.
  • said tube is flexible enough to bend with a turning radius smaller than 5 mm.
  • the apparatus comprises at least one catheter guide adapted to lie within a coronary sinus, said guide including a channel which defines a pathway that includes a substantially right angle turn, with a turning radius of less than 15 mm.
  • said anchor is preassembled with said elongate tensioning element.
  • said tube includes a separate guide wire channel.
  • the apparatus comprises a guidewire which is sharp enough and stiff enough to penetrate cardiac muscle.
  • said at least one anchor is configured to lie on an outside of a left ventricle and is in the form of a pad.
  • said at least one anchor is configured to lie on an outside of a left ventricle and includes a plurality of elongate extensions adapted to lie against said outside.
  • said at least one anchor is configured to lie on an outside of a left ventricle and has a surface area for contact with said surface, of at least 6 sq. cm.
  • said at least one anchor is a hook adapted to engage a rod-like element.
  • said at least one anchor is a rod-like element.
  • said elongate tensioning element dissipates after less than 6 months. In an exemplary embodiment of the invention, said elongate tensioning element has a length of between 4 and 15 cm.
  • coronary sinus guide apparatus comprising:
  • said guide is fixed.
  • flow of blood past and around said guide to an opposite end of said body is substantially blocked.
  • the portion of said body extending past said guide is substantially solid and having a cross-section of at least 80% of a cross-sectional area of said body.
  • the apparatus comprises a guide wire channel extending past said guide and leading into said partial lumen.
  • said guidewire channel is positioned relative to said guide and said partial lumen in a manner which impedes insertion of a guide wire through said partial lumen and into said guide wire channel.
  • said channel is substantially continuous with a wall of said partial lumen.
  • the apparatus comprises a guide wire with an at least partially pre-bent tip.
  • the apparatus comprises a funnel-like wire guide at an entrance to said partial lumen.
  • the apparatus comprises an anchoring element at least one end of said body.
  • said body has a minimal cross-sectional diameter of less than 15 mm in a part designated for the coronary sinus, such that the coronary sinus would not be blocked by the apparatus.
  • said body is long enough and stiff enough to modify a shape of a Mitral valve annulus.
  • the apparatus is configured for permanent implantation in a coronary sinus.
  • the apparatus comprises a catheter adapted to fit through said aperture and including a tip for penetrating cardiac muscle tissue.
  • a method of treating a heart comprising:
  • said coupling and said second coupling comprise: releasing an anchor distal to said second wall; and releasing a second anchor proximal to said first wall.
  • said penetrating comprises penetrating with a hollow tube.
  • said penetrating comprises penetrating a wall of the left ventricle from outside of the heart.
  • said penetrating comprises penetrating a wall of the left ventricle from inside of the heart.
  • said accessing comprises accessing through a vascular system.
  • said accessing comprises accessing through an atrial septum.
  • said accessing comprises accessing through a coronary sinus.
  • the method comprises adjusting a length of said elongate tensioning element inside said heart.
  • the method comprises selecting a desired effect on said heart of said elongate tensioning element and selecting the locations of said penetrations in accordance with said selecting.
  • the method comprises treating a disorder selected from the group of Heart failure, Mitral valve insufficiency and Dilated Cardiomyopathy, using said elongate tensioning element.
  • the method comprises repeating at least one of said coupling and said second coupling for a plurality of elongate tensioning elements.
  • said (b) penetrating and said second penetrating (c) comprise penetrating at other than apical and papillary muscle positions.
  • said coupling and said second coupling are selected so that said elongate tensioning element is not tensioned by said walls over the entire cycle of the heart.
  • cardiac tensioning apparatus comprising:
  • a method of having a beneficial effect on a heart comprising:
  • said at least one elongate tensioning element comprises a plurality of elongate tensioning elements.
  • said at least one elongate tensioning element is not implanted at a papillary muscle or an apex of the heart
  • the pressure applied to the portion of the heart is at least during ventricular diastole. In some embodiments, the pressure applied to a portion of the heart is at least during ventricular systole.
  • the second anchor is deployed at least partially inside the transverse pericardial sinus of the heart. In some embodiments, the second anchor is deployed inside the transverse pericardial sinus of the heart. In some embodiments, the second anchor is deployed at least partially inside the left ventricle, contacting the aortic-mitral curtain portion of the mitral valve annulus. In some embodiments, the second anchor comprises an annuloplasty ring or an artificial heart valve.
  • the second anchor is deployed so as to engage an implantable prosthesis, e.g., an annuloplasty ring or a prosthetic heart valve. In some embodiments, the second anchor is deployed so as to engage a previously-deployed implantable prosthesis such as an annuloplasty ring or a prosthetic heart valve.
  • a method for applying pressure to at least a portion of a mammalian heart inside which an implantable prosthesis e.g., an annuloplasty ring, a prosthetic heart valve
  • an implantable prosthesis e.g., an annuloplasty ring, a prosthetic heart valve
  • a method for applying pressure to at least a portion of a mammalian heart inside which an implantable prosthesis comprising: a) providing an implantable device including a first anchor (such as described above), a second anchor (such as described above) and at least one elongated tensioning member (such as described above); b) deploying the first anchor so as to contact an external wall of a left ventricle of the heart (as described above); c) (optionally while the heart is beating) engaging the implantable prosthesis so as to deploy the second anchor in proximity to a mitral valve annulus of the heart; and d) for at least a first of the tensioning members, securing a first portion of the tensioning member to the first anchor and securing
  • the pressure applied to the portion of the heart is at least during ventricular diastole. In some embodiments, the pressure applied to a portion of the heart is at least during ventricular systole. In some embodiments, the second anchor is deployed at least partially inside the transverse pericardial sinus of the heart. In some embodiments, the second anchor is deployed at least partially inside the left ventricle, contacting the aortic-mitral curtain portion of the mitral valve annulus. In some embodiments, the heart is the heart of a non-human animal. In some embodiments, the heart is the heart of a human. In some embodiments, the heart is the heart of a non-living animal.
  • the tensioning member passing through the left ventricle substantially avoids penetrating a papillary muscle.
  • the first anchor is deployed so as to contact an external wall of the left ventricle in proximity of the apex of the heart.
  • the first anchor is deployed substantially entirely outside the heart. In some embodiments, the tensioning member passes from the first anchor through at least a portion of an external wall of the left ventricle of the heart. In some embodiments, the tensioning member passes from the first anchor through an external wall of the left ventricle of the heart.
  • the first anchor comprises at least one assembly including a contact face and the deploying of the first anchor comprises placing the contact face against an outer surface of the heart.
  • the first anchor comprises at least two discrete assemblies each including a contact face and the deploying of the first anchor comprises placing the contact face of each assembly against a different part of an outer surface of the heart.
  • the method further comprises: at least one day after "d" (the securing of a first portion of the tensioning member to the first anchor and the securing of a second portion of a tensioning member to the second anchor), changing a distance separating the first anchor and the second anchor defined by a tensioning member.
  • the changing of the distance decreases the pressure applied to the heart.
  • the changing of the distance increases the pressure applied to the heart.
  • changing the distance comprises engaging the first anchor and/or the tensioning member (proximal to the first anchor, e.g., from the direction of the cardiac apex) so as to change the distance, in some embodiments while the heart is beating.
  • changing the distance comprises engaging the second anchor and/or the tensioning member (proximal to the second anchor) from the transverse pericardial sinus of the heart so as to change the distance, in some embodiments while the heart is beating.
  • the implantable device comprises at least two of the tensioning members, and the method further comprises, for each of the tensioning members: securing a first portion of the tensioning member to the first anchor and securing a second portion of the tensioning member to the second anchor so that the tensioning member passes through the left ventricle thus defining a distance separating the first anchor and the second anchor when the tensioning member is taut so that the first anchor and the second anchor apply pressure to a portion of the heart.
  • the method further comprises: at least one day after "d" (securing a first portion of the tensioning member to the first anchor and securing a second portion of the tensioning member to the second anchor), changing a distance separating the first anchor and the second anchor defined by at least one the tensioning member. In some embodiments the method further comprises: at least one day after "d” (securing a first portion of the tensioning member to the first anchor and securing a second portion of the tensioning member to the second anchor), changing a distance separating the first anchor and the second anchor defined by at least two the tensioning members.
  • changing a distance defined by a tensioning member comprises, engaging the second anchor and/or the tensioning member (in proximity of the second anchor) from the transverse pericardial sinus of the heart so as to change the distance, in some embodiments while the heart is beating.
  • changing a distance defined by a tensioning member comprises engaging the first anchor and/or the tensioning member (in proximity of the first anchor, for example from the direction of the cardiac apex) so as to change the distance, in some embodiments while the heart is beating.
  • an implantable device for applying pressure to at least a portion of a mammalian heart that in some embodiments is useful for implementing some embodiments of the methods described above, the implantable device, comprising: a) a first anchor configured for contacting a surface of an external wall of a left ventricle of a heart; b) a second anchor configured for deployment in proximity to the aortic side of a mitral vaive annulus of a heart; and c) at least one flexible elongated tensioning member secured to the first anchor and to the second anchor thus substantially defining a distance separating the first anchor and the second anchor when the tensioning member is taut.
  • the second anchor is configured for deployment at least partially inside the left atrium of a heart.
  • the second anchor comprises an annuloplasty ring or an artificial heart valve.
  • the second anchor is configured to engage an implantable prosthesis such as an annulopiasty ring or prosthetic heart valve, in some embodiments a previously-deployed implantable prosthesis such as an annuloplasty ring or prosthetic heart valve.
  • the second anchor is configured to contact the aortic-mitral curtain portion of a mitral valve annulus.
  • the second anchor is configured for deployment at least partially inside the transverse pericardial sinus of a heart.
  • the second anchor is configured for deployment inside the transverse pericardial sinus of a heart.
  • the second anchor comprises an elongated member configured to fit inside a transverse pericardial sinus, for example having a length of between about 1 cm and about 6 cm (in some embodiments between about 1 cm and about 2 cm) and a width of between about 2 mm and about 5 mm (in some embodiments between about 2 mm and about 3 mm).
  • a second anchor is axially flexible.
  • such a second anchor is a substantially rigid rod, in some embodiments a straight or curved rod.
  • an implantable device for applying pressure to at least a portion of a mammalian heart comprising: a) a first anchor configured for contacting a surface of an external wall of a left ventricle of a heart; b) a second anchor configured for deployment in proximity a mitral valve annulus of a heart by engaging an implantable prosthesis (e.g., an annuloplasty ring, a prosthetic heart valve) previously deployed inside a heart; and c) at least one flexible elongated tensioning member secured to the first anchor and to the second anchor thus substantially defining a distance separating the first anchor and the second anchor when the tensioning member is taut.
  • an implantable prosthesis e.g., an annuloplasty ring, a prosthetic heart valve
  • the second anchor is configured for deployment at least partially inside the left atrium of a heart. In some embodiments, the second anchor is configured to contact the aortic-mitral curtain portion of a mitral valve annulus. In some embodiments, the second anchor is configured for deployment at least partially inside the transverse pericardial sinus of a heart. In some embodiments, the tensioning member is filamentous.
  • the tensioning member is configured to slidingly pass through heart tissue.
  • the first anchor is expandable, for example comprises an expandable wire mesh.
  • the first anchor is configured for deployment at least partially outside of a heart. In some embodiments, the first anchor is configured for deployment substantially entirely outside of a heart.
  • the first anchor comprises a single assembly including a contact face configured for contacting a surface of an external wall of a left ventricle of a heart. In some embodiments, the first anchor comprises at least two discrete assemblies, each assembly including a contact face configured for contacting a surface of an external wall of a left ventricle of a heart, the first anchor configured to be deployed so that a contact face of each assembly contacts a different portion of a surface of an external wall of a left ventricle of a heart. In some embodiments, the contact faces of at least one (and in some embodiments all) the assemblies of a first anchor of a device have a surface area of at least about 4 cm 2 and even at least about 6 cm 2 . In some embodiments, the contact faces of at least one (and in some embodiments all) the assemblies of a first anchor of a device have an area of no more than about 25 cm 2 and even no more than about 15 cm 2 .
  • At least one contact face is concave.
  • at least one assembly of a first anchor comprises a plate curved so that the contact face is concave.
  • a first anchor when deployed a first anchor substantially maintains a shape to support the surface of a heart which is being contacted and distributing pressure over a greater surface area.
  • an assembly of a first anchor is substantially rigid or, alternatively, elastic and slightly flexible.
  • at least one assembly of a first anchor includes a pliant layer associated with the contact face, e.g., a layer of felt, sponge, fabric or tissue such as heterologous or homologous serous tissue.
  • the second anchor comprises a single assembly.
  • At least part of the second anchor is expandable, for example comprises an expandable wire mesh.
  • the device comprises a single tensioning member.
  • the device comprises at least two tensioning members.
  • the first anchor is configured to allow at least two tensioning members to be secured thereto at substantially the same location. In some embodiments, the first anchor is configured to allow at least two tensioning members to be secured thereto at substantially different locations.
  • the second anchor is configured to allow at least two tensioning members to be secured thereto at substantially the same location.
  • the second anchor is configured to allow at least two tensioning members to be secured thereto at substantially different locations.
  • a tensioning member is fixedly securable to the first anchor.
  • the securing of a tensioning member to the first anchor comprises a portion of the tensioning member encircling a portion of the first anchor.
  • the securing of a tensioning member to the first anchor comprises a portion of the tensioning member passing through a portion of the first anchor.
  • the securing of a tensioning member to the second anchor comprises a portion of the tensioning member encircling a portion of the second anchor.
  • the securing of a tensioning member to the second anchor comprises a portion of the tensioning member passing through a portion of the second anchor.
  • a tensioning member and the first anchor are configured so that the tensioning member is reversibly securable to the first anchor when the device is deployed in a heart.
  • a tensioning member and the second anchor are configured so that the tensioning member is reversibly securable to the second anchor when the device is deployed in a heart.
  • a distance defined by a tensioning member is adjustable.
  • the device is configured so that a distance defined by a tensioning member is adjustable when the device is deployed in a heart.
  • the distance defined by a tensioning member is adjustable by changing the location of a tensioning member through which the tensioning member is secured to the first anchor.
  • the device is configured so that the distance is adjustable by engaging the first anchor and/or the tensioning member (in embodiments near the first anchor).
  • the device is configured so that the distance defined by a tensioning member is adjustable when the device is deployed in a heart.
  • the device is configured so that the distance is adjustable from the direction of the apex of the heart.
  • the distance is adjustable by changing the location of a tensioning member through which the tensioning member is secured to the second anchor.
  • the device is configured so that the distance defined by a tensioning " member is adjustable by engaging the second anchor and/or the tensioning member (in embodiments near the second anchor). In some embodiments, the device is configured so that the distance defined by a tensioning member is adjustable when the device is deployed in a heart. In some embodiments, the device is configured so that the distance is adjustable from the transverse pericardial sinus.
  • a device of the present invention is not provided fully assembled, but rather is assembled, at least partially, from separate components during deployment.
  • a kit for assembling a device substantially as discussed above for applying pressure to at least a portion of a mammalian heart comprises a) a first anchor configured for contacting a surface of an external wall of a left ventricle of a heart.
  • the first anchor is substantially as described above.
  • a kit further comprises b) a second anchor configured for deployment in proximity to the aortic side of a mitral valve annulus of a heart.
  • a kit further comprises b) a second anchor configured for deployment in proximity of a mitral valve annulus of a heart by engaging an implantable prosthesis previously deployed inside a heart.
  • the second anchor is substantially as described above.
  • a kit of the present invention comprises at least one tensioning member configured to be secured to the first anchor and to the second anchor, thereby substantially defining a distance separating the first anchor and the second anchor when the tensioning member is taut.
  • the at least one tensioning member is substantially as described above.
  • a tensioning member provided with a kit is cuttable and, when cut, constitutes at least two separate tensioning members, each configured to be secured to the first anchor and to the second anchor.
  • a tensioning member is provided as a spool of suture material or a long piece of suture material.
  • At least one component of a device of the present invention are configured for minimally invasive deployment, for example a delivery catheter or a transapical probe.
  • At least one component from amongst the first anchor and the second anchor is configured to fit inside a minimally-invasive delivery device. In some embodiments, the at least one component is packed inside such a minimally invasive delivery device.
  • both the first anchor and the second anchor are configured for packing in a minimally-invasive delivery device. In some embodiments, both the first anchor and the second anchor are packed inside such a minimally invasive delivery device.
  • the minimally-invasive delivery device is a delivery catheter. In some embodiments, the minimally-invasive delivery device is a transapical probe. In some embodiments, at least some components of a device are provided held within a transapical probe, configured to penetrate at or near the apex of a heart (and in some cases near the base of the papillary muscles), and to deploy the held components therein. For example, in some embodiments, a second anchor and a tensioning member, substantially as described above, are provided held inside a transapical probe. For example, in some embodiments, a first anchor, a second anchor and a tensioning member, substantially as described above, are provided held inside a transapical probe.
  • At least some components of a device are provided held within a deployment catheter, configured to enter a heart and to deploy the held components therein.
  • a first anchor and a tensioning member are provided held inside a deployment catheter.
  • a first anchor, a second anchor and a tensioning member are provided held inside a deployment catheter.
  • method refers to manners, means, techniques and procedures for accomplishing a given task including, but not limited to, those manners, means, techniques and procedures either known to, or readily developed from known manners, means, techniques and procedures by practitioners of the chemical, pharmacological, biological, biochemical and medical arts.
  • the terms “comprising” and “including” or grammatical variants thereof are to be taken as specifying the stated features, integers, steps or components but do not preclude the addition of one or more additional features, integers, steps, components or groups thereof.
  • This term encompasses the terms “consisting of and “consisting essentially of.
  • the phrase “consisting essentially of or grammatical variants thereof when used herein are to be taken as specifying the stated features, integers, steps or components but do not preclude the addition of one or more additional features, integers, steps, components or groups thereof but only if the additional features, integers, steps, components or groups thereof do not materially alter the basic and novel characteristics of the claimed composition, device or method.
  • FIG. 1 is a schematic depiction of a healthy heart in cross section
  • FIGs. 2A and 2B depict a mitral valve of a healthy heart
  • FIGs. 3A and 3B depict a mitral valve of a heart suffering from ischemic mitral regurgitation related to incomplete coaptation of the leaflets of the mitral valve;
  • FIGs. 4A, 4B and 4C depict an embodiment of a device for applying pressure to portions of a heart comprising a first anchor including a curved plate of stainless steel mesh and an axially flexible second anchor;
  • FIG. 4D is a schematic depiction of a heart showing the transverse pericardial sinus
  • FIG. 4E is a schematic depiction of a top view of a heart with the atria removed;
  • FIGs. 5A and 5B depict an embodiment of a device for applying pressure to portions of a heart comprising a first anchor including a curved plate of PMMA mesh and a second anchor including a rigid curved cylinder of stainless steel;
  • FIGs. 6A and 6B depict an embodiment of a device for applying pressure to portions of a heart comprising a first anchor including two discrete assemblies and a second anchor;
  • FIGs. 7A-7I depict an embodiment of a device configured for minimally invasive transapical deployment and deployment thereof
  • Fig. 8F shows a layout including two devices in a heart, in accordance with an exemplary embodiment of the invention.
  • FIGs. 9A-9G depict an embodiment of a device configured for trans catheter deployment and deployment thereof
  • FIGs. 10A-10E illustrate a guide for a trans-coronary sinus approach, in accordance with an exemplary embodiment of the invention, at various stages of use thereof;
  • FIGs. 11 A-111 illustrate stages in a deployment of a device via a coronary sinus, using a guide according to FIGs. 10A-10E, in accordance with an exemplary embodiment of the invention.
  • an implantable device comprising at least one flexible elongated tensioning member connecting between two anchors is deployed in the heart.
  • the first anchor is deployed on the outer surface of the left ventricle and the second anchor is deployed in proximity of the mitral valve annulus so that the tensioning member passes through the left ventricle.
  • the tensioning member substantially defines a distance separating the first anchor and the second anchor when the tensioning member is taut so that the first anchor and the second anchor each apply pressure to a portion of the heart.
  • the second anchor and/or elongate tensioning element may be provided at various sides of the mitral valve.
  • multiple anchors and/or cables may be provided at different points along the annulus of the mitral valve
  • the first anchor may be located, for example, at middle of the posterior mitral annulus and/or in between the two trigones, depending on the desired effect on the heart.
  • the second anchor is configured for deployment in proximity of a mitral valve annulus by engaging an implantable prosthesis (e.g., an annuloplasty ring, a prosthetic heart valve) previously and/or concurrently deployed inside a heart.
  • an implantable prosthesis e.g., an annuloplasty ring, a prosthetic heart valve
  • Some such embodiments are potentially useful for "retrofitting" a heart that has been previously been treated by deployment of a prosthetic heart valve or annuloplasty ring, possibly with a relatively reduced level of trauma to the heart. For example, in some cases due to continued remodeling of the heart, the leaflets of an annuloplasty ring-supported mitral valve exhibit insufficient coaptation.
  • Some embodiments of the present invention allow for improvement of the leaflet coaptation by deploying a device including a second anchor that engages the previously deployed annuloplasty ring without necessitating a more traumatic intervention such as replacement of the annuloplasty ring and/or Mitral valve.
  • the second anchor is configured for deployment in proximity to the aortic side of the mitral valve annulus, for example in proximity of the midseptal fibrous annulus.
  • Some such embodiments take advantage of the relative toughness and tenacity of the fibrous parts of the heart to support the second anchor and to distribute pressures in the heart with comparatively little trauma.
  • the first and/or second anchor are positioned and/or configured (e.g., size of contact area) to engage other fibrous parts of the heart.
  • an implantable device comprising more than one flexible elongated tensioning member connecting between two anchors is deployed in the heart.
  • different tensioning members each independently define a distance between a first anchor and a second anchor when taut.
  • a plurality e.g., 2, 3, 4, or more
  • implantable devices are used in a same heart, optionally sharing an anchor.
  • devices are added over time, as needed.
  • previously implanted devices are removed and/or tightened and/or loosened, as needed.
  • the force and/or movement limitation applied to the heart by the implantable device has at least one beneficial effect.
  • beneficial effect is meant that the device has an effect such as curing a condition, treating a condition, preventing a condition, treating symptoms of a condition, curing symptoms of a condition, ameliorating symptoms of a condition, treating effects of a condition, ameliorating effects of a condition, and preventing results of a condition.
  • the applied pressure changes the shape of the cardiac walls and/or of the left atrium.
  • the device is implanted in other chambers of the heart and/or across two or more heart chambers.
  • a device serves to have a beneficial effect (e.g., to positively remodel) other chambers and/or valves of the heart.
  • the force applied on the heart by the anchors supports sagging portions of the cardiac walls.
  • the device relieves and/or redistributes pressure inside the heart.
  • the device ameliorates and even reverses at least some of the effects of cardiac remodeling.
  • the pressure applied on the outer surface of the left ventricle by the first anchor pushes the outer wall of the left ventricle upwards, bringing the papillary muscles and the chordae towards the mitral valve, improving coaptation of the mitral valve leaflets.
  • the pressure applied on the outer surface of the left ventricle supports a portion of the heart wall that is sagging or weakened, for example due to cardiac remodeling, muscle death and/or cardiomyopathy.
  • the device is provided using a minimally invasive approach.
  • the heart is not stopped during such treatment.
  • the approach is from outside the heart (e.g., keyhole surgery), for example using a trans-apical (the heart, however, need not be penetrated specifically at the apex).
  • the approach is trans-septal using a catheter.
  • the approach is via a coronary sinus into the left atrium and/or left ventricle.
  • some embodiments of the present invention are useful for treating a condition related to cardiac remodeling, for example ischemic mitral regurgitation.
  • ischemic mitral regurgitation a condition related to cardiac remodeling
  • FIG. 1 A condition related to cardiac remodeling
  • FIG. 1 A condition related to cardiac remodeling
  • FIG. 1 A condition related to cardiac remodeling
  • FIG. 1 A condition related to cardiac remodeling
  • FIG. 1 A condition related to cardiac remodeling
  • FIG. 1 A condition related to cardiac remodeling
  • Some embodiments of a device of the present invention are devices that, when properly implanted in the body of a mammal, apply force to and/or limit motion of at least a portion of a heart, and as such in some embodiments are useful for implementing the method of the present invention.
  • Some embodiments of a device of the present invention comprise a) a first anchor configured for contacting a surface of an external wall of a left ventricle of a heart; b) a second anchor configured for deployment in proximity to a mitral valve annulus of a heart; and c) at least one elongated tensioning member secured to the first anchor and to the second anchor thus substantially defining a distance separating the first anchor and the second anchor when the tensioning member is taut. It should be noted that the order of application of the anchors may be different in different embodiments of the invention.
  • the second anchor is configured for deployment in proximity of'a mitral valve annulus by engaging an implantable prosthesis (e.g., an annuloplasty ring, a prosthetic heart valve) previously deployed inside a heart.
  • an implantable prosthesis e.g., an annuloplasty ring, a prosthetic heart valve
  • the prosthesis includes a rod like element, such as the body of the ring or an annulus of the valve.
  • the prosthesis includes an aperture, slot and/or other structure adapted to cooperate with an anchoring part of the implantable device.
  • the second anchor is configured for deployment in proximity to the aortic side of the mitral valve annulus, for example in proximity of the midseptal fibrous annulus.
  • a tensioning member is a flexible elongated component. In some embodiments, a tensioning member is substantially axially unstretchable or substantially resistant to axial stretching. In some embodiments, a tensioning member is configured to slidingly pass through heart tissue.
  • the tensioning element is coated or formed to not adhere to tissue. This may assist in later removal thereof.
  • the tensioning element is elastic, for example, designed to elongate under tension.
  • the elastic properties of such a member are selected to match a desired dynamic effect on the heart, for example, allowing the heart to dilate during exercise and/or assist systole by recoiling (e.g., assisting the heart to contract using elastic energy stored in the member during diastole).
  • the member is resilient and can extend during diastole, possibly assisting refilling during diastole.
  • assistance to contracting and/or other functioning of the heart is at least of an order of 3%, 5%, 10%, 20%, 30% or intermediate percentage increase in cardiac output.
  • the member is selected and located so as to increase pre-stretching of some parts of the heart, which are optionally healthy, thereby increasing a contraction force thereof during systole.
  • one or more tensioning members are secured to the first anchor and to the second anchor, each tensioning member defining a distance separating the first anchor from the second anchor when the tensioning member is taut.
  • the tensioning member (and/or an attachment thereof to the anchors) are designed with a tension limit, above which the member fails in a known manner, for example, tearing at a previously weakened point or elongating by a known amount.
  • the tension limit is selected to avoid physiological damage to the heart.
  • a tensioning member is configured to pass through heart tissue.
  • a tensioning member passes through the external wall of a left ventricle (e.g., in proximity of the cardiac apex) when deployed, especially the portion of a tensioning member near the first anchor.
  • a tensioning member passes through tissue in the vicinity of a mitral valve annulus (for example when passing from the left ventricle to the transverse pericardial sinus) when deployed, especially the portion of a tensioning member near the second anchor.
  • a device of the present invention comprises a single tensioning member secured to the first anchor and to the second anchor.
  • a device of the present invention comprises at least two tensioning members.
  • a first anchor is configured to allow at least two separate tensioning members to be secured thereto, each tensioning member from a different orientation or direction.
  • a first anchor is configured to allow two tensioning members to be secured to substantially the same location of the first anchor.
  • a first anchor is configured to allow two tensioning members to be secured to substantially different locations of the first anchor.
  • a second anchor is configured to allow at least two separate tensioning members to be secured thereto, each tensioning member from a different orientation or direction.
  • a second anchor is configured to allow two tensioning members to be secured to substantially the same location of the second anchor.
  • a second anchor is configured to allow two tensioning members to be secured to substantially different locations of the second anchor.
  • a tensioning member is filamentous.
  • filamentous is meant a tensioning member comprising a component such as a fiber, a filament, a ribbon, a cord, a rope, a strand, a thread, a cable, a wire or yarn.
  • the member is formed as a ribbon or is otherwise configured to not flex equally easily in different directions.
  • the member is made somewhat resilient.
  • the resilience prevents the member form looping and/or otherwise engaging parts of the heart when the heart contracts.
  • a tensioning member comprises a filament or the like made of a synthetic polymer, a natural polymer and/or of an inorganic material.
  • a filament or the like is coated, for example to reduce thrombogenicity, to increase biostability, reduce friction with cardiac tissue and/or to increase biocompatibility.
  • Inorganic materials that in some embodiments are suitable for implementing a tensioning member of the present invention include metal and metal alloy filaments, such as of silver, gold, titanium or stainless steel.
  • Natural polymers that in some embodiments are suitable for implementing a tensioning member of the present invention include cotton, linen and silk.
  • Synthetic polymers that in some embodiments are suitable for implementing a tensioning member of the present invention include fluorinated hydrocarbons (e.g., polytetrafluorethyiene), polyesters (e.g., Dacron® (E. I. du Pont de Nemours and Company, Wilmington, DE, USA)), polyethylenes (e.g., Ultra-High Molecular Weight polyesters such as Dyneema® (DSM, Heerlen, the Netherlands), Spectra® (Honeywell, Morisstown, NJ, USA)) and polyamides (e.g., Nylons, such as Nylon 6-6, aromatic polyamides such as Kevlar® (E. I. du Pont de Nemours and Company, Wilmington, DE, USA)).
  • Suitable tensioning members for example, include sutures of sufficient strength, for example 3-0 Prolene non-resorbable sutures.
  • the member is made biodegradable and/or includes a biodegradable portion that dissipates over time in the body and/or blood, so that the function of the device is stopped.
  • such degradation is designed to occurs after 1 week, 1 month, 5 months and/or other, intermediate or greater periods of time, depending, for example, on a desired effect and/or duration thereof.
  • the member includes multiple filaments, some of which degrade and some which do not.
  • the non- degrading filaments allow a greater degree of motion between the anchors and/or do not impose limits on the heart, but maintain the anchors in place.
  • such an effect of changing of member length over time is provided by folding over the tensioning element and maintaining the fold with a biodegrading adhesive, element (e.g., band) and/or sleeve.
  • a biodegrading adhesive e.g., band
  • Various biodegrading materials, including plastics are known in the art and may be used.
  • dissipate is used to describe a state in which an implant structure is compromised, for example, due to dissolving, sorption, attack by blood components and/or chemical change, which may cause, for example, parts of the structure to be carried away, fall off, dissolve and/or weaken. After time, the structure may disappear completely.
  • a first anchor of a device of the present invention is configured for contacting a surface of an external wall of a left ventricle of a heart, possibly, but not necessarily the apex.
  • a first anchor of the present invention is termed an "apical anchor" due to the deployment of the first anchor at or near a cardiac apex, for example in the area of the external wall of the left ventricle across from the base of the papillary muscles, or at an area of left ventricle which is weakened, diseased and/or bulges.
  • a first anchor is configured to be at least partially, and in some embodiments entirely, deployed outside of a heart.
  • a first anchor comprises only a single assembly including a contact face configured for contacting a surface of an external wall of a left ventricle of a heart.
  • the anchor only contacts the wall and is not configured to engage the wall (e.g., is smooth and/or has no sutures).
  • the anchor is coated with materials that enhance fibrosis and/or otherwise enhance engagement of the wall by the anchor.
  • an adhesive is provided. Such treatment and/or design may be applied to other anchors as well.
  • a first anchor comprises at least two assemblies, each assembly including a contact face configured for contacting a surface of an external wall of a left ventricle of a heart, the first anchor being configured to be deployed so that a contact face of each assembly contacts a different portion of a surface of an external wall of a left ventricle of a heart.
  • a first anchor comprises at least two discrete assemblies.
  • one, more than one or all of the contact faces of the one or more assemblies of a first anchor have a surface area that is at least about 4 cm 2 and even at least about 6 cm 2 . In some embodiments, the contact faces of one, more than one, or all of the assemblies of a first anchor have an area of no more than about 25 cm 2 and even no more than about 15 cm 2 . In an exemplary embodiment of the invention, the contact area and/or force distributing elements in the anchor (e.g., metallic ribs) are designs to support an otherwise ballooning section of the heart.
  • the contact face has a rounded shape, e.g., round, oval, elliptical, oblate.
  • a contact face has an oval or elliptical shape that has a large dimension of between 2 cm and 5 cm and a small dimension of between 1.5 cm and 3 cm.
  • at least one contact face is concave so as to follow the curvature of the surface of the left ventricle.
  • at least one assembly of a first anchor comprises a plate curved so that the contact face is concave.
  • the contact face is flat and/or has another shape which is not simply concave, for example, including ridges or other protrusions.
  • a first anchor substantially maintains a shape to support the contacted surface of a heart and distributes pressure over a greater surface area of the heart.
  • an assembly of a first anchor is substantially rigid or, alternatively, is elastic and slightly flexible.
  • Exemplary materials from which a first anchor is made include a plastic (e.g., PMMA), a metal (e.g., Nitinol), or a mesh.
  • the anchor includes a plurality (e.g., 2, 3,
  • the anchor being formed as a plurality of members that extend away form a common center (e.g., to which the tensioning element is attached.
  • an outer ring interconnects at least some of the members.
  • the anchor is formed in the shape of a ring.
  • at least a portion of a first anchor is expandable (e.g., including unfoldable).
  • the anchor is rigid.
  • a first anchor is configured for minimally-invasive delivery, for example with the help of a delivery catheter (e.g., trans-septal and/or via coronary sinus) or a transapical probe.
  • a delivery catheter e.g., trans-septal and/or via coronary sinus
  • a transapical probe e.g., trans-septal and/or via coronary sinus
  • a first anchor is configured to fit inside a delivery device (for example is expandable, for example comprises an expandable wire mesh).
  • At least a portion of a first anchor is provided packed in a delivery device (for example, an expandable first anchor packed while in a non-expanded state) such as a delivery catheter or a transapical probe.
  • a delivery device for example, an expandable first anchor packed while in a non-expanded state
  • at least one assembly of a first anchor includes a pliant layer associated with the contact face, e.g., a layer of felt, sponge, fabric or tissue such as heterologous or homologous serous tissue.
  • a pliant layer reduces pressure trauma on the surface of the heart and more evenly distributes the pressure over the surface of the heart.
  • a first anchor comprises one or more assemblies that are similar in construction (although in some embodiments different in shape and/or dimensions) to pads such as used in implementing the Coapsys® device commercially available from Myocor, Inc.
  • the anchor attachment to the tensioning member and/or the anchor itself are flexible enough to provide some give to the implantable device, when in use.
  • the point of attachment is formed as a cone with its point towards the heart.
  • the anchor lies outside the heart, this need not be the case.
  • the anchor is designed to expand inside muscle tissue and/or is a helix which screws into muscle tissue.
  • the anchor comprises two plates, one inside the heart and on outside the heart, on opposite sides of the cardiac wall, sandwiching the wall between them
  • the anchor is desired to degrade after a time in the body, Optionally, a time substantially longer that required for tissue adhesion to the tensioning member and/or time for dissipation of the tensioning member.
  • the anchor is large enough to constraining the expansion (and/or assist in contraction) of the left ventricle as a whole, for example, being a cup shaped anchor with a contact surface area of at least 10 cm 2 , 20 cm 2 , 30 cm 2 , 40 cm 2 or intermediate areas.
  • the tensioning member is then used to maintain such a constraining element in place and optionally not to have a geometry limiting function.
  • the geometry limiting functions of the anchor an the member and/or of the second anchor cooperate to have a desired effect.
  • Second (mitral) anchor In some embodiments, a second anchor of a device of the present invention is configured for deployment in proximity to a mitral valve annulus of a heart.
  • a second anchor of the present invention is termed a "mitral anchor" due to the deployment of the second anchor near a mitral valve annulus.
  • a second anchor comprises a single assembly.
  • the second anchor is configured for deployment at least partially inside the left atrium of a heart. In other embodiments, the anchor is anchored outside the heart.
  • a second anchor is configured for deployment in proximity to the aortic side of a mitral valve annulus of a heart, for example in proximity of a midseptal fibrous annulus.
  • a tensioning member secured to a second anchor enters the left ventricle from the area roughly between the aortic valve and the anterior leaflet side of the mitral valve, underneath or through the mitral valve annulus.
  • the second anchor is configured to rest against or otherwise contact the aortic mitral curtain portion of a mitral valve annulus.
  • the second anchor comprises a prosthesis device such as an annuloplasty ring or prosthetic heart valve.
  • the second anchor is configured for deployment at least partially inside the transverse pericardial sinus of the heart. Such embodiments may be advantageous for one or more of a number of reasons. In some such embodiments at least some of the pressure applied by the second anchor to the heart is applied to a relatively tough outer surface of the heart, reducing trauma. In some such embodiments the pressure applied by the second anchor is applied to and distributed by the fibrous cardiac tissue (e.g., midseptal fibrous annulus) located between the aortic valve and the mitral valve, optionally due to anchoring at the location of the transverse pericardial sinus just over these fibrous tissues.
  • the fibrous cardiac tissue e.g., midseptal fibrous annulus
  • placement of the second anchor primarily in the transverse pericardial sinus and thus outside of the cardiac chambers reduces the chance that a deployed device directly substantially changes the flow of blood inside the heart.
  • placement of the second anchor at least partially inside the transverse pericardial sinus avoids the application of substantial and/or direct pressure to the mitral valve annulus, allowing the mitral valve annulus to function normally (e.g., to contract during ventricular systole) without distortion.
  • the second anchor is substantially an elongated member optionally configured to fit inside the transverse pericardial sinus of a heart.
  • the second anchor has a length of between about 1 cm and about 6 cm (in some embodiments between about 1 cm and about 2 cm) and a width of between about 2 mm and about 5 mm (in some embodiments between about 2 mm and about 3 mm) so as to fit inside a transverse pericardial sinus.
  • a second anchor is axially flexible allowing the second anchor to conform and better fit inside the transverse pericardial sinus and to bend with the beating of the heart.
  • a second anchor is a substantially rigid rod (e.g., a straight or curved rod).
  • a second anchor is semi-rigid, for example, like the Physio® annuloplasty ring available from Edwards Life sciences (Irvine, CA, USA).
  • a second anchor is expandable.
  • a second anchor is configured for minimally-invasive delivery, for example with the help of a delivery catheter or a transapical probe.
  • a second anchor is configured to fit inside a delivery device (for example is expandable, for example comprises an expandable wire mesh or a folded rod).
  • at least a portion of a second anchor is provided packed in a delivery device (for example, an expandable second anchor packed while in a non-expanded state) such as a delivery catheter or a transapical probe.
  • a second anchor is fashioned from materials such as known in the art of annuloplasty rings, for example nitinol, stainless steel shape memory materials, metals, synthetic biostable polymer, a natural polymer, an inorganic material, titanium, pyrolytic carbon, a plastic, a titanium mesh or polydimethylsiloxane.
  • materials such as known in the art of annuloplasty rings, for example nitinol, stainless steel shape memory materials, metals, synthetic biostable polymer, a natural polymer, an inorganic material, titanium, pyrolytic carbon, a plastic, a titanium mesh or polydimethylsiloxane.
  • a biostable polymer from which a second anchor is fashioned comprises a material from the group including a polyolefin, polyethylene, a fluorinated hydrocarbon such as polytetrafluoroethylene (Teflon®), a polycarbonate synthetic, a polyurethane, a fluorinated polyolefin, a chlorinated polyolefin, a polyamide, an acrylate polymer, an acrylamide polymer, a vinyl polymer, a polyacetal, a polycarbonate, a polyether, an aromatic polyester, a polyether (ether ketone), a polysulfone, a silicone rubber (e.g., Silastic by Dow-Corning Corporation, Midland, Ml, USA), a thermoset material, or a polyester (ester imide, for example Dacron® by Invista, Wichita, KS, USA) and/or combinations thereof.
  • a fluorinated hydrocarbon such as polytetrafluoroethylene (Tef
  • a second anchor is configured to allow a tensioning member secured thereto to pass through the second anchor.
  • a second anchor is made of a piercable material, for example silicone rubber or felt.
  • a second anchor is provided with holes, gaps or channels allowing passage of tensioning member therethrough, for example, a second anchor fashioned of a titanium mesh.
  • a second anchor is configured to localize a tensioning member looped around and encircling the second anchor, thereby preventing slippage along the second anchor.
  • such configuration comprises, for example ridges, bumps, grooves and other like features on an outer surface of the second anchor.
  • a second anchor is configured to engage an implantable prosthesis previously deployed in the heart.
  • a second anchor is configured to engage an annuloplasty ring deployed in proximity of a mitral valve annulus in the usual way.
  • a second anchor is configured to engage a prosthetic heart valve deployed in proximity of a mitral valve annulus in the usual way.
  • Such embodiments are possibly useful by allowing implementation of the teachings of some embodiments of the present invention (especially minimally-invasive embodiments of the present invention) to subjects previously treated, for example with the deployment of an annuloplasty ring or prosthetic heart valve, where the results of the previous treatment are unsatisfactory, for example as a result of continued remodeling of the heart.
  • the second anchor is an annuloplasty ring.
  • such a ring is not separately attached to the heart, other than being held by the tensioning element.
  • such a ring includes one or more spikes to engage cardiac tissue, at least when the ring tensioned by said tensioning member.
  • the ring is sutured to cardiac tissue.
  • the second anchor is located inside a coronary sinus.
  • the anchor is an annuloplasty ring located inside the coronary sinus.
  • the anchor only has an anchoring function.
  • the second anchor is a hook adapted to hook an annuloplasty ring (or other prosthesis) inside the coronary sinus or inside the left atrium.
  • the designs of the anchors may depend on the desired use of the device.
  • the device is anchored on both sides to free expanses of the heart (e.g., left ventricle side and right ventricle side) and the anchor is of the apical deign for both sides.
  • various features described above with reference to an apical anchor may be applied to a mitral anchor.
  • one or both anchors and/or the tensioning member elute a pharmaceutical (e.g. vascular endothelial growth factors (VEGF)).
  • a pharmaceutical e.g. vascular endothelial growth factors (VEGF)
  • one or more radio-opaque markers are provided in the device, for example, to allow easy assessment of its location and/or integrity via x-ray imaging and/or echo (ultrasound) imaging (for which acoustic markers may be provided).
  • a tensioning member and a first anchor are configured so that the tensioning member is fixedly securable to the first anchor.
  • a tensioning member and a second anchor are configured so that the tensioning member is fixedly securable to the second anchor.
  • the securing of a tensioning member to a first anchor comprises a portion of the tensioning member encircling a portion of the first anchor.
  • the securing of a tensioning member to a second anchor comprises a portion of the tensioning member encircling a portion of the second anchor.
  • the securing of a tensioning member to a first anchor comprises a portion of the tensioning member passing through a portion of the first anchor. In some embodiments, the securing of a tensioning member to a second anchor comprises a portion of the tensioning member passing through a portion of the second anchor.
  • a tensioning member and the first anchor are configured so that the tensioning member is reversibly securable to the first anchor when deployed in a heart. In some embodiments, a tensioning member and the second anchor are configured so that the tensioning member is reversibly securable to the second anchor when deployed in a heart.
  • a distance defined by a tensioning member is adjustable.
  • the device is configured so that a distance defined by a tensioning member is adjustable when the device is deployed in a heart.
  • the adjustability is during deployment of the device.
  • the adjustability is after the device is deployed in a heart for some time, for example after at least one day.
  • the device is configured so that the distance is adjustable by engaging the first anchor and/or the second anchor and/or the tensioning member.
  • the anchor and/or tensioning member include a thread and the adjusting is by rotation of one relative to the other.
  • the anchor is locked to the tensioning element by a screw which is provided in the anchor and rotated to engage the tensioning element.
  • the tensioning element is wrapped around a suitable projection of the anchor.
  • the anchor is crimped on the tensioning element.
  • the tensioning element includes one or more widened portions, for example, beads, which are engaged by an aperture in the anchor which is not wide enough for the widened part of the anchor to pass through.
  • the anchor comprises an aperture in the form of two side by side and connected (e.g., by a slot) apertures, one wide enough for the tensioning element at any diameter thereof and one only wide enough for the narrowed sections of the tensioning element.
  • the tensioning member includes a plurality of projections axially distributed, which, together with one or more projections in an aperture of the anchor, define a ratcheting element, allowing one way retraction of the tensioning member through the anchor aperture.
  • the distance defined by a tensioning member is adjustable by changing the location of a tensioning member through which the tensioning member is secured to the first anchor.
  • the device is configured so that the distance is adjustable by engaging the first anchor and/or the tensioning member (in embodiments near the first anchor).
  • the device is configured so that the distance defined by a tensioning member is adjustable when the device is deployed in a heart.
  • the device is configured so that the distance is adjustable from the direction of the cardiac apex.
  • the distance is adjustable by changing the location of a tensioning member through which the tensioning member is secured to the second anchor.
  • the device is configured so that the distance defined by a tensioning member is adjustable by engaging the second anchor and/or the tensioning member (in embodiments near the second anchor).
  • the device is configured so that the distance defined by a tensioning member is adjustable when the device is deployed in a heart.
  • the device is configured so that the distance is adjustable from a transverse pericardial sinus. Kits
  • a device of the present invention is not provided fully assembled, but rather is provided at least partially disassembled in the form of a kit, in embodiments packaged in a sterility-preserving package. In such embodiments, the device is assembled during deployment in a heart. In other embodiments, the device is provided fully assembled and loaded within a minimally-invasive delivery tube such as a catheter or a trans- apical delivery system.
  • a kit of the present invention comprises a first anchor configured for contacting a surface of an external wall of a left ventricle of a heart. .
  • the first anchor is substantially as described above.
  • a kit of the present invention comprises a second anchor configured for deployment in proximity of a mitral valve annulus of a heart.
  • the second anchor is substantially as described above.
  • a kit of the present invention comprises at least one tensioning member configured to be secured to the first anchor and to the second anchor, thereby substantially defining a distance separating the first anchor and the second anchor when the tensioning member is taut.
  • the at least one tensioning member is substantially as described above.
  • a tensioning member provided with a kit is cuttable and, when cut, constitutes at least two separate tensioning members, each configured to be secured to the first anchor and to the second anchor.
  • a tensioning member is provided as a spool of suture material or a long piece of suture material.
  • a device of the present invention is provided with at least some components packed in a minimally-invasive delivery device, such as a transapical probe or a delivery catheter.
  • a device of the present invention is provided with a first anchor and a tensioning member associated therewith packed inside a delivery catheter.
  • the device is also provided with a second anchor associated with the tensioning member and packed inside the delivery catheter.
  • the components of a device are configured for serial deployment through a distal end of the delivery catheter.
  • the first anchor for example, is packed closer to the distal end of the delivery catheter than other components, so as to allow the first anchor to be deployed prior to deployment of other components.
  • a device of the present invention is provided with a second anchor and a tensioning member associated therewith packed inside a transapical probe.
  • the device is also provided with a first anchor associated with the tensioning member and packed inside the transapical probe.
  • the components of a device are configured for serial deployment through a distal end of the transapical probe.
  • the second anchor for example, is packed closer to the distal end of the transapical probe than other components, so as to allow the second anchor to be deployed prior to deployment of other components.
  • embodiments of the method of the present invention are described hereinbelow with reference to deployment of exemplary embodiments of the device of the present invention. It should be noted that embodiments of the invention also include implementations where different features are provided form different embodiments, for example, materials, sizes, structures, material properties and/or process steps.
  • FIGs 4A to 4E a first embodiment of a device for applying pressure, force and/or movement limitation to a portion of a mammalian heart of the present invention, device 52 is depicted.
  • device 52 is depicted deployed in an ischemic heart 50.
  • Device 52 comprises three discrete components: a pad assembly as a first anchor 54, a felt rod as a second anchor 56 and a suture strand as a tensioning member 58.
  • First anchor 54 is depicted in detail in Figure 4B in front view and side view.
  • First anchor 54 is a single assembly consisting essentially of two components: a slightly-elastic curved plate of stainless steel mesh 60, 3 cm by 5 cm wide (having a surface area of about 12 cm 2 ) and a pliant layer 62 of 0.5 mm thick surgical felt located on the concave face of plate 60 so as to define a concave contact face 64.
  • First anchor 54 is configured to be deployed entirely outside heart 50 so that contact face 64 contacts a surface 66 of an external wall 68 of left ventricle 28 of heart 50 in proximity of cardiac apex 70. Contact face 64 of first anchor 54 rests against the epicardium covering surface 66 of heart 50. Being made of a mesh plate 60 and a pliant layer 62, first anchor 54 is piercable and therefore configured to allow the passage of tensioning member 58 therethrough.
  • Second anchor 56 comprises a 2 cm long, 3 mm diameter rod of surgical felt configured to fit inside transverse pericardial sinus 72 of heart 50, in proximity to the aortic side of mitral valve annulus 34 over the midseptal fibrous annulus. Being made from felt, second anchor 56 is axially bendable and radially compressible and is thereby configured to fit inside transverse pericardial sinus 72 and to change in shape to accommodate the changes of shape of transverse pericardial sinus 72 as heart 50 beats. Being made of felt, second anchor 56 is also piercable and is thereby configured to allow the passage of tensioning member 58 therethrough.
  • Tensioning member 58 is filamentous, flexible, and is substantially a loop of axial unstretchable, 3-0 Prolene non-resorbable suture strand cut to the appropriate length and secured to first anchor 54 and second anchor 56, as depicted in Figure 4C.
  • tensioning member 58 passes through first anchor 54 at two locations defined by holes 78a and 78b, encircling a portion of first anchor 54 and ensuring that pressure is evenly applied to surface 66 of external wall 68 of heart 50.
  • the two ends of the suture strand making up tensioning member 58 pass through second anchor 56 at two substantially different locations, each location near a different end of second anchor 56. The ends of the suture strand are knotted together thereby constituting tensioning member 58.
  • tensioning member 58 substantially defines a distance separating first anchor 54 and second anchor 56.
  • mitral portion 74 of tensioning member 58 passes through cardiac tissue making up the roof of left ventricle 28 partially underneath and partially through mitral valve annulus 34 into the volume of left ventricle 28.
  • apical portion 76 of tensioning member 58 penetrates into and passes through external wall 68 of left ventricle 28 into the volume of left ventricle 28.
  • Tensioning member 58 is smooth and slidingly passes through the heart tissue during the beating of heart 50.
  • the heart 50 For deployment of device 52, the heart 50 exposed, for example with a median sternotomy the patient is attached to a heart-lung machine, the beating of heart 50 stopped and a standard annuloplasty ring 80 is deployed, in the usual way, on the atrial side of mitral valve
  • Device 52 is provided disassembled as a kit comprising first anchor 54.
  • Second anchor 56 is fashioned ad hoc from a piece of surgical felt found in a surgical theater and tensioning member 58 is fashioned ad hoc from suture strand also found in a surgical theater.
  • a kit comprises a first anchor 54 and a second anchor 56.
  • a kit comprises a first anchor 54, a second anchor 56 and suture strand (for example a spool of suture strand) constituting tensioning member 58.
  • First anchor 54 is placed against surface 66 of a portion of external wall 68 that is sagging as a result of a remodeling process.
  • the ends of a length of the suture strand are threaded through the eyes of two surgical needles, each end to a needle.
  • a first needle together with the accompanying end of the suture strand is passed through plate 60 of first anchor 54 at hole 78a, through pliant layer 62 to penetrate into and through external wall 68 of left ventricle 28.
  • the first needle is passed through the roof of left ventricle 28 underneath (or through) the aortic side of mitral valve annulus 34 (hatched area in Figure 4E where heart 50 is depicted with atria 12 and 24 removed) to emerge out into transverse pericardial sinus 72 (hatched area in Figure 4D), thereby drawing a first length of the suture strand across the volume of left ventricle 28.
  • a second needle together with the accompanying end of the suture strand is passed through plate 60 of first anchor 54 at hole 78b, through pliant layer 62 to penetrate into and through external wall 68 of left ventricle 28 and passed through the roof of left ventricle 28 underneath (or through) the aortic side of mitral valve annulus 34 to emerge out into transverse pericardial sinus 72, thereby drawing a second length of the suture strand across the volume of left ventricle 28.
  • the suture strand penetrates through first anchor 54 in two places (holes 78a and 78b) and encircles a portion thereof.
  • Second anchor 56 is pushed slidingiy downwards along the suture strand to contact the bottom of transverse pericardial sinus 72 so as to be deployed in proximity to the aortic side of mitral valve 26 of heart 50.
  • the two ends of the suture are brought together to constitute a loop that is tensioning member 58 and thus to secure tensioning member 58 to first anchor 54 and second anchor 56.
  • the beating of heart 50 is restarted and the patient disconnected from the heart-lung machine.
  • the two ends of the suture strand are pulled to shorten tensioning member 58 and thus decrease the distance between first anchor 54 and second anchor 56.
  • the two ends of the suture strand are released to lengthen tensioning member 58 and thus increase the distance between first anchor 54 and second anchor 56.
  • the change in the structure of mitral valve 26, coaptation and alignment of leaflets 38 and 40 and the degree of regurgitation is monitored until the surgeon performing the deployment of device 52 decides that the length of tensioning member 58 is sufficient.
  • the ends of the suture strand are secured together by knotting and the procedure ended. In other embodiments, the suture is fixed in place prior to restarting the heart.
  • heart 50 beats.
  • tensioning member 58 is held taut.
  • Contact face 64 presses against surface 66 of external wall 68, supporting the sagging portion of heart 50.
  • Papillary muscles 44 are prevented from moving outwards, reducing the tension applied by chordae 46 on leaflets 38 and 40, allowing leaflets 38 and 40 to properly coapt, reducing mitral regurgitation.
  • the support of the sagging portion of external wall 68 of left ventricle 28 together with the improvement of mitral valve leaflet coaptation may reverse cardiac remodeling or have other positive effects.
  • Pliant layer 62 optionally acts as shock absorber, reducing pressure-trauma during beating of heart 50 and distributing pressure on surface 66 more evenly than otherwise.
  • FIGs 5A and 5B a second embodiment of a device of the present invention, device 82 is depicted, in Figure 5A deployed in an ischemic heart 50.
  • the distance between first anchor 54 and second anchor 56 is adjustable when deployed in a heart 50, and even when heart 50 is beating.
  • First anchor 54 of device 82 is substantially similar to first anchor 54 of device 52 but is made of PMMA (polymethyl methylacrylate) instead of stainless steel.
  • First anchor 54 of device 82 is configured so that tensioning member 58 is reversibly securable to first anchor 54 when device 82 is deployed in a heart 50 and, in some embodiments, while heart 50 is beating.
  • first anchor 54 is provided with a retaining nut 84 with an axial hole passing therethrough to accommodate a tensioning member 58 and a locking screw 86 disposed in a screw hole perpendicular to the axial hole.
  • Such a construction allows the location along tensioning member 58 where tensioning member 58 is secured to first anchor 54 to be changed.
  • Second anchor 56 of device 82 is a rigid curved cylinder of stainless steel, 3 cm long and 2 mm in diameter. Midway between the ends of second anchor 56 is a groove 88.
  • Tensioning member 58 of device 82 is suture strand similar to tensioning member 58 of device 52. Mitral portion 74 of tensioning member 58 is formed into a loop that rests inside groove 88 and encircles second anchor 56.
  • Apical portion 76 of tensioning member 58 is a single length of suture strand which passes through the axial hole of retaining nut 84.
  • Locking screw 86 is screwed inwards in retaining nut 84 to an extent that locking screw 86 engages a part of apical portion 76 of tensioning member 58 to secure tensioning member 58 to first anchor 54.
  • An embodiment of the method of the present invention is implemented by deploying device 82 in a heart 50.
  • a patient is attached to a heart-lung machine, the beating of heart 50 stopped and heart
  • Device 82 is provided disassembled as a kit comprising first anchor 54, second anchor 56 and a spool of suture strand constituting tensioning member 58.
  • Contact face 64 of first anchor 54 is placed against portion of external wall 68 of heart
  • Mitral portion 74 of tensioning member 58 is threaded through the eye of a surgical needle.
  • Apical portion 76 of tensioning member 58 is threaded through the axial hole in retaining nut 84.
  • the needle together with mitral portion 74 of tensioning member 58 is passed through plate 60 of first anchor 54, through pliant layer 62 to penetrate into and through external wall 68 of left ventricle 28.
  • the needle is passed through the roof of left ventricle 28 underneath (or through) the aortic side of mitral valve annulus 34 to emerge out into transverse pericardial sinus 72, thereby drawing tensioning member 58 across the volume of left ventricle 28.
  • the needle is detached from tensioning member 58 and mitral portion 74 of tensioning member 58 is looped around so as to encircle second anchor 56 and the loop tightened to rest inside groove 88, preventing mitral portion 74 of tensioning member 58 from sliding along the length of second anchor 56.
  • retaining nut 84 is held against first anchor 54, apical portion 76 of tensioning member 58 is carefully pulled outwards from heart 50, drawing mitral portion 74 and second anchor 56 into transverse pericardial sinus 72 until second anchor 56 rests at the bottom of transverse pericardial sinus 72.
  • Apical portion 76 of tensioning member 58 is pulled outwards through the axial hole of retaining nut 84 until the length of tensioning member 76 is such that a desired distance is defined between first anchor 54 and second anchor 56.
  • Locking screw 86 is tightened to engage a location along apical portion 76 of tensioning member 58 to maintain the selected length of tensioning member 58 and thus the distance between first anchor 54 and second anchor 56.
  • the beating of heart 50 is restarted and the structure of mitral valve 26, coaptation and alignment of leaflets 38 and 40 and the degree of regurgitation is observed, for example with the help of TEE. If the surgeon performing the deployment of device 82 determines that it is necessary, the length of tensioning member 58 is adjusted by loosening locking screw 86 and then apical portion 76 of tensioning member 58 is valed to shorten tensioning member 58 and thus decrease the distance between first anchor 54 and second anchor 56 or apical portion 76 is released to lengthen tensioning member 58 and thus increase the decrease the distance between first anchor 54 and second anchor 56.
  • Locking screw 86 is tightened to engage a location along apical portion 76 to maintain the selected length of tensioning member 58 and thus the distance between first anchor 54 and second anchor 56. The adjustment of the length of tensioning member 58 is repeated until the performing surgeon determines that the length is correct and the procedure is ended.
  • apical portion 76 of tensioning member 58 and first anchor 54 are configured so that tensioning member 58 is reversibly securable to first anchor 54, when deployed, rendering the distance between first anchor 54 and second anchor 56 adjustable when deployed.
  • tensioning member 58 If after a time (e.g., a few days) there is a reason, for example a clinical reason, to change the distance defined by tensioning member 58, apical portion 76 of tensioning member 58, first anchor 54, retaining nut 84 and locking screw 86 are engaged from the direction of apex 70, for example using standard cardiothoracic surgical techniques through a median sternotomy. While apical portion 76 of tensioning member 58 is grasped (to avoid escape into heart 50) locking screw 86 is released.
  • a time e.g., a few days
  • the distance defined between second anchor 56 and first anchor 54 is either increased by allowing apical portion 76 to pull back into heart 50 (reducing the pressure applied on heart 50) or decreased by pulling apical portion 76 outwards (increasing the pressure applied on heart 50) while holding first anchor 54 against heart 50.
  • locking screw 86 is tightened to fix apical portion 76 in place.
  • the distance is adjustable by changing the location of apical portion 76 through which tensioning member 58 is secured to first anchor 54.
  • first anchor 54 comprises two discrete assemblies 54a and 54b with two discrete tensioning members 58a and 58b.
  • Each tensioning member 58a and 58b defines a distance between a second anchor 56 and a respective assembly 54a and 54b.
  • Each of the distances is independently adjustable when device 92 is deployed in a heart 50 even when heart 50 is beating.
  • Each first anchor assembly 54a and 54b of device 82 is substantially similar to pads used in a Coapsys® device (Myocor, Inc., Maple Grove, MN, USA).
  • Second anchor 56 of device 92 is a 2 cm length of surgical felt having a 3 mm diameter oblate semicircular cross section. Second anchor 56 of device 92 is configured allowing a tensioning member 58a or 58b to be reversibly securable to second anchor 56 when device 92 is deployed in heart 50 and, in some embodiments, while heart 50 is beating. Specifically, second anchor 56 is provided with two retaining nuts 84a and 84b each with an axial hole passing therethrough to accommodate a tensioning member 58a or 58b and a locking screw 86a or 86b disposed in a screw hole parallel to the axial hole.
  • Each tensioning member 58a or 58b is a single length of suture strand like tensioning member 58 of device 52.
  • Apical portions 76a or 76b of tensioning members 58a and 58b pass through a hole in a respective first anchor assembly 54a or 54b.
  • Mitral portions 74a or 74b pass through an axial hole of a retaining nut 84a or 84b.
  • a locking screw 86a or 86b is screwed inwards in a retaining nut 84a or 84b to an extent that the locking screw engages a respective part of a mitral portion 74a or 74b to secure a tensioning member 58a or 58b to second anchor 56.
  • An embodiment of a method for applying pressure to a heart is implemented by deploying device 92 in a heart 50.
  • a patient is attached to a heart-lung machine, the beating of heart 50 stopped and heart 50 exposed, for example with a median sternotomy.
  • an annuloplasty ring 80 is deployed in heart 50.
  • Device 92 is provided disassembled as a kit comprising first anchor assemblies 54a and 54b, second anchor 56 and a spool of suture strand constituting tensioning members 58a and 58b.
  • Mitral portion 74a of tensioning member 58a is threaded through the eye of a surgical needle.
  • Apical portion 76a of tensioning member 58a is secured to first anchor assembly 54a.
  • the needle together with mitral portion 74a of tensioning member 58a is passed through a portion of external wall 68 of heart 50 that is sagging as a result of a remodeling process to penetrate into and through external wall 68 of left ventricle 28.
  • the needle is passed through the roof of left ventricle 28 underneath (or through) the aortic side of mitral valve annulus 34 to emerge out into transverse pericardial sinus 72, thereby drawing tensioning member 58a across the volume of left ventricle 28.
  • Mitral portion 74b of tensioning member 58b is threaded through the eye of a surgical needle.
  • Apical portion 76b of tensioning member 58b is secured to second anchor assembly 54b.
  • the needle together with mitral portion 74b of tensioning member 58b is passed through a portion of external wall 68 of heart 50 that is sagging as a result of a remodeling process to penetrate into and through external wall 68 of left ventricle 28.
  • the needle is passed through the roof of left ventricle 28 underneath (or through) the aortic side of mitral valve annulus 34 to emerge out into transverse pericardial sinus 72, thereby drawing tensioning member 58b across the volume of left ventricle 28.
  • Mitral portions 74a and 74b of tensioning members 58a and 58b are passed through the felt material of second anchor 56 and threaded through the axial holes in retaining nuts 84a and 84b. Second anchor 56 is allowed to slide along tensioning members 58a and 58b until coming to rest at the bottom of transverse pericardial sinus 72.
  • mitral portions 74a and 74b of tensioning members 58a and 58b are independently pulled to shorten a respective tensioning member 58 and thus decrease the distance between a first anchor assembly 54a or 54b and second anchor 56 or, alternatively, released to lengthen a respective tensioning member 58 and thus increase the distance between a first anchor assembly 54a or 54b and second anchor 56.
  • the change in the structure of mitral valve 26, coaptation and alignment of leaflets 38 and 40 and the degree of regurgitation is observed until the surgeon performing the deployment of device 92 decides that the length of tensioning members 58a and 58b is sufficient.
  • Locking screws 86a and 86b are tightened to engage a location along mitral portion 74a or 74b to maintain the selected length of the respective tensioning member 58a or 58b and thus the distance between the first anchor assembly 54a or 54b and second anchor 56.
  • the procedure is ended. After the patient recovers, heart 50 beats and device 92 functions substantially as described above for device 52.
  • mitral portions 74a and 74b of tensioning members 58 and second anchor 56 are configured so that tensioning members 58 are reversibly securable to second anchor 56, when device 92 is deployed in a heart 50, rendering the distances between first anchor assemblies 54a and 54b and second anchor 56 adjustable when deployed in heart 50. If after a time (e.g., a few days) there is a reason, for example a clinical reason, to change one or both distances defined by tensioning members 58, mitral portions 74 of tensioning members 58, second anchor 56, retaining nuts 84 and locking screws 86 are engaged from the direction of transverse pericardial sinus 72, for example using a median sternotomy.
  • a time e.g., a few days
  • a respective locking screw 86a or 86b is released.
  • the distance defined between second anchor 56 and a first anchor assembly 54a or 54b is either increased by allowing a respective mitral portion 74 to pull back into heart 50 (reducing the pressure applied on heart 50) or decreased by pulling a respective mitral portion 74 outwards while holding second anchor 56 against heart 50 (increasing the pressure applied on heart 50).
  • the locking screw 86 is tightened to fix mitral portion 74 in place.
  • one or more distances are adjustable by changing the location of a mitral portion 74 through which a respective tensioning member 58 is secured to second anchor 56.
  • first anchor 54 of device 92 depicted in Figures 6 comprises two discrete assemblies 54a and 54b.
  • a first anchor of a device comprises more than two discrete assemblies.
  • Device 92 depicted in Figures 6 comprises two tensioning members 58a and 58b. In some embodiments, a device comprises more than two tensioning members.
  • Device 92 depicted in Figures 6 comprises two tensioning members 58a and 58b secured to different locations of second anchor 56. In some embodiments, more than one tensioning member is secured to substantially the same location of a second anchor.
  • Device 92 depicted in Figures 6 comprises two tensioning members 58a and 58b secured to different locations of second anchor 56, each tensioning member secured to a different assembly of first anchor 54. In some embodiments, more than one tensioning member is secured to substantially the same location of a first anchor.
  • FIG. 7A and 7B A fourth embodiment of a device of the present invention, device 94, is depicted in Figures 7A and 7B.
  • Device 94 is configured for minimally-invasive transapical deployment.
  • Various stages of minimally-invasive transapical deployment of device 94 are depicted in Figures 7C to 71.
  • device 94 is depicted packed inside a hollow transapical probe 96 configured for use with a transthorax surgical robot (such as the da Vinci® Surgical Robot by Intuitive Surgical, Inc., Sunnyvale, California, USA). In other embodiments, for example as described below, the probe is held manually.
  • a shape-memory wire mesh constituting first anchor 54 Inside the bore of transapical probe 96 are seen components of device 94: a shape-memory wire mesh constituting first anchor 54, a shape- memory wire mesh constituting second anchor 56, a suture filament as a tensioning member 58 and a crimpable retainer ring 98.
  • device 94 is depicted released from the constraints of the bore of transapical probe 96.
  • first anchor 54 when allowed to expand, first anchor 54 optionally adopts the shape of concave-convex disk with a concave side defining a contact face 64 facing second anchor 56. Also seen is that when allowed to expand, second anchor 56 optionally adopts a rod-shape suitable in size and shape to fit inside a transverse pericardial sinus 72. Both first anchor 54 and second anchor 56 are optionally shape-memory wire mesh configured to self-expand when released from the constraints of the bore of transapical probe 96.
  • First anchor 54 and second anchor 56 are optionally made from materials and in a manner with which a person having ordinary skill in the art is familiar, and are analogous to anchors such as taught in the patent publications US 2006/0241340, US 2007/0203391 and US 2007/0078297. Other anchor designs may be used as well.
  • a mitral portion 74 of tensioning member is optionally made from materials and in a manner with which a person having ordinary skill in the art is familiar, and are analogous to anchors such as taught in the patent publications US 2006/0241340, US 2007/0203391 and US 2007/0078297. Other anchor designs may be used as well.
  • tensioning member 58 passes into and is secured (for example by tying or looping) to the mesh making up second anchor 56.
  • An apical portion 76 of tensioning member 58 passes through a base ring 100 in the center of first anchor 54. Encircling tensioning member 58 in a proximal direction from the convex side of first anchor 54 is crimpable retainer ring 98.
  • first anchor 54 when packed inside transapical probe 96, first anchor 54 is in contact with a first push rod 102.
  • First push rod 102 passes from the proximal end of transapical probe 96 (not depicted), to contact the proximal side of first anchor 54.
  • Transapical probe 96 is configured to allow actuation of first push rod 102 to push first anchor 54 out of transapical probe 96.
  • the rod is configured as a tube or other means such as known in the art for pushing an object out of a tube.
  • a short spike extends form probe 96, such that when probe 96 is retracted, the spike engages surrounding tissue and pulls out first anchor 54.
  • Second anchor 56 when packed inside transapical probe 96, second anchor 56 is close to piercing tip 104 of transapical probe 96 and in contact with a second push rod 106.
  • Second push rod 106 passes from the proximal end of transapical probe 96 (not depicted), through base ring 100 of first anchor 54 to contact the proximal side of second anchor 56.
  • Transapical probe 96 is configured to allow actuation of second push rod 106 to push second anchor 56 out of transapical probe 96.
  • crimpable retainer ring 98 is encircled by the jaws of crimper-cutter 108.
  • Transapical probe 96 is configured to allow actuation of crimper-cutter 108, closing the jaws to crimp crimpable retainer ring 98 around tensioning member 58.
  • blades inside crimper cutter 108 (not visible in the Figures) cut through a portion of tensioning member 58 that passes therebetween, proximally to crimpable retainer ring 98.
  • tensioning member 58 is prefixed to the two anchors and no crimping mechanism is needed.
  • a minimally-invasive transapical embodiment of the method of the present invention for applying pressure to a heart is implemented by deploying device 94 in a heart 50 of a subject.
  • transapical probe 96 with device 94 loaded therein is mounted on a suitable surgical robot and the subject is appropriately prepared while heart 50 is still beating.
  • the heart is stopped.
  • the probe is used with a larger opening in the chest, for example, as part of an open chest procedure with sternum opening.
  • transapical probe 96 is directed, optionally in the usual way, between the ribs of the subject, to penetrate into a left ventricle 28 of heart 50 near apex 70 or at a different desired location, for example, through a portion of external wall 68 that is sagging as a result of a remodeling process.
  • transapical probe 96 is directed so as to pass clear through the base of left ventricle 28, underneath (or through) the aortic side of mitral valve annulus 34 to emerge out into transverse pericardial sinus 72. In some embodiments, other sides of the mitral valve are targeted.
  • second push rod 106 is actuated, pushing second anchor 56 out of the bore of transapical probe 96. Freed of constraints, second anchor 56 expands to fit inside transverse pericardial sinus 72.
  • probe 96 is withdrawn from heart 50 trailing tensioning member 58.
  • first push rod 102 is actuated, pushing first anchor 54 out of the bore of transapical probe 96. Freed of constraints, first anchor 54 expands to the expanded concave- convex lens shape where the concave side faces surface 66 of heart 50.
  • anchor 54 is configured to seal bleeding form the left ventricle.
  • tensioning member 58 is drawn taut while the end of crimper-cutter 108 is pressed against crimpable retainer ring 98 and base ring 100 of first anchor 54.
  • the tension applied by tensioning member 58 is optionally varied while viewing the magnitude of regurgitation into left atrium during ventricular systole with an imaging modality (e.g., TEE) as described above: the tension is increased to decrease the distance between first anchor 54 and second anchor 56 as defined by tensioning member 58 and the tension is decreased to increase the distance between first anchor 54 and second anchor 56.
  • TEE imaging modality
  • tensioning member 58 is prefixed to the anchors and no adjusting need be done.
  • a plurality of second anchors are applied by repositioning the tip of probe 96 while probe 96 still transfixed the left atrium.
  • heart 50 beats.
  • tensioning member 58 is held taut.
  • Contact face 64 presses against surface 66 of external wall 68, supporting the sagging portion of heart 50.
  • Papillary muscles 44 are prevented from moving outwards, reducing the tension applied by chordae 46 on leaflets 38 and 40, allowing leaflets 38 and 40 to properly coapt, reducing mitral regurgitation.
  • the support of the sagging portion of external wall 68 of left ventricle 28 together with the improvement of mitral valve leaflet coaptation reverses cardiac remodeling.
  • first anchor 54 and second anchor 56 allow the anchors to act as shock absorbers, reducing pressure-trauma during beating of heart 50 and distributing pressure on surface 66 more evenly than otherwise.
  • a fifth embodiment of a device of the present invention, device 100 is depicted in Figures 8A to 8E.
  • device 110 is configured for transapical deployment, with a number of noteworthy differences, one or more of which may be applied in various embodiments of the invention.
  • device 94 is deployed with the help of transapical probe 96 that is configured to hold and deploy substantially all components of device 94, including first anchor 54, second anchor 56, tensioning member 58 and crimpable retainer ring 98.
  • a transapical probe for deploying a device of the present invention is configured to hold and deploy fewer components.
  • device 110 only second anchor 56 and tensioning member 58 are held within and deployed with the help of transapical probe 96.
  • an apical section 76 of tensioning member 58 is left trailing from the puncture in heart 50 through which transapical probe 96 entered.
  • First anchor 54 is then deployed, substantially as described above, for example through a hole in the thorax, optionally via a tubular delivery system, such as probe 96, and secured to apical section 76 of tensioning member 58.
  • transapical probe 96 that is configured for use with a surgical robot.
  • a transapical probe for deploying a device of the present invention is configured for manual use, optionally similarly to known transapical probes.
  • second anchor 56 of device 94 is optionally deployed outside the heart in the transverse pericardial sinus.
  • a second anchor 56 is deployed inside a left atrium 24 on the aortic- mitral curtain portion of the mitral valve annulus.
  • FIGs 8A to 8E Various stages of minimally-invasive transapical deployment of device 110 are depicted in Figures 8A to 8E.
  • device 110 is depicted packed inside a hollow transapical probe 96 configured for manual use through a left anterior mini thoracotomy procedure, for example, being similarly to known transapical probes, for example as described in PCT patent publications WO 2007/059252 or WO/2007/016187.
  • a second anchor 56 Inside the bore of transapical probe 96 are seen two components of device 110: a second anchor 56 and a tensioning member 58.
  • Second anchor 56 is substantially a foldable wire mesh configured to self-expand when released from the constraints of the bore of transapical probe 96 analogous to the described above for device 94.
  • Transapical probe 96 is configured to allow actuation of push rod 106 to push second anchor 56 out of transapical probe 96.
  • a minimally-invasive transapical embodiment of a method for applying pressure to a heart is optionally implemented by deploying device 110 in a heart 50 of a patient.
  • the patient is optionally prepared in the usual way (e.g., a left anterior thoracotomy) and the piercing tip 104 of transapical probe 96 directed near apex 70 of heart 50 through a portion of external wall 68 that is sagging as a result of a remodeling process.
  • the heart is optionally stopped, however, it is often desirable to not stop the heart and/or not attach the patient to a heart-lung machine.
  • transapical probe 96 is directed so as to pass clear through the base of the heart 28, near or through the fibrotic part of mitral valve annulus 34 and through an annuloplasty ring or band if present, to emerge out into left atrium 24.
  • the penetration is in two steps, with a first step being penetrating into the left ventricle, followed by aiming at a desired point in the wall separating the left ventricle from the left atrium.
  • the second anchor is deployed inside the wall of the heart, so no penetration into the left atrium is actually provided.
  • push rod 106 is actuated, pushing second anchor 56 out of the bore of transapical probe 96. Freed of constraints, second anchor 56 expands inside left atrium 24.
  • probe 96 is withdrawn from heart 50 and out of the incision in the thorax of the subject, trailing tensioning member 58.
  • tensioning member 58 is optionally drawn taut and the tension applied by tensioning member 58 is optionally varied while viewing the magnitude of regurgitation into left atrium during ventricular systole (and/or other cardiac parameter it is desired to change) with an imaging modality in the usual way: the tension is increased to decrease the distance between first anchor 54 and second anchor 56 as defined by tensioning member 58 and the tension is decreased to increase the distance between first anchor 54 and second anchor 56.
  • the change in the structure of mitral valve 26, coaptation and alignment of leaflets 38 and 40 and the degree of regurgitation is monitored until the surgeon performing the deployment of device 110 decides that the length of tensioning member 58 is sufficient.
  • the length of tensioning member 58 is fixed.
  • the heart may be stressed (e.g., using pharmaceuticals) and/or its preload and/or afterload changed, to ascertain operational parameters of the device.
  • Fig. 8E The end result is shown in Fig. 8E. It should be noted that the approach direction and/or final layout of the device depend on the desired effect on the heart.
  • heart 50 beats and device 110 functions substantially as described above.
  • second anchor 56 of device 110 is configured to be deployed inside the left ventricle, resting against or engaging the aortic-mitral curtain portion of a mitral valve annulus.
  • a second anchor of a device configured for deployment inside the left ventricle is configured to rest against or engage (e.g., via a hook) an a ⁇ nuloplasty ring and/or suture ring and/or other prosthesis also deployed in the heart, for example, in the left atrium and/or in the coronary sinus (in which case a longer hook may be desired).
  • an annuloplasty ring may be considered as a portion or an entire second anchor of a device.
  • a second anchor of a device configured for minimally invasive deployment inside the left ventricle is configured to rest against or engage an annuloplasty ring deployed in the heart prior to deployment of a device, see, for example, below.
  • Fig. 8F shows an example where a plurality of devices are deployed.
  • a strand 58' is coupled to an outside of the left ventricle via a separate first anchor 54'.
  • a separate second anchor is optionally provided.
  • the two first anchors are one large anchor.
  • the two devices are deployed at different times. Such a deployment may be practiced with any of the methods/embodiments described herein.
  • FIG. 9A to 9H A sixth embodiment of a device of the present invention, device 112, is depicted in Figures 9A to 9H.
  • device 112 is configured for transcatheter deployment.
  • devices 94 and 110 are configured for deployment with the help of a transapical probe 96 that enters the body through the thorax, for example through a left anterior mini thoracotomy.
  • a device is configured for deployment by a transcatheter, technique for example that passes through blood vessels to the site of deployment in the heart.
  • device 110 includes a second anchor 56 configured for deployment inside a left atrium 24 on the aortic-mitral curtain portion of the mitral valve annulus.
  • device 112 includes a second anchor 56 configured for deployment inside a left atrium of a heart.
  • a device is provided with a second anchor that is configured to rest against or otherwise engage a previously deployed implantable prosthesis such as an annuloplasty ring or a prosthetic heart valve.
  • device 112 is deployed from a base of the heart, and the first (apical) anchor is loaded in a distal part of the delivery system, rather than the second anchors, as described above.
  • Device 112 as optionally packed in a delivery catheter 114, is depicted in Figures 9A and 9B.
  • Delivery catheter 114 includes a main lumen 116 and a guide wire lumen 118. Inside main lumen 116 are seen components of device 112: a shape memory wire mesh constituting a first anchor 54, a stainless steel hook with base 120 constituting a second anchor 56 (in some embodiments, a different form of second anchor, for example, a rod or folded rod, is provided), a suture filament as a tensioning member 58 and an optional crimpable retainer ring 98.
  • device 112 is depicted released from the constraints of delivery catheter 114. It is seen that, when allowed to expand, first anchor 54 adopts the shape of concave-convex disk with a concave side defining a contact face 64 facing second anchor 56.
  • tensioning member 58 passes into and is secured (for example by tying or looping) to the first anchor, for example, to a mesh making up first anchor 54.
  • a mitral portion 74 of tensioning member 58 passes through base 120 of second anchor 56. Encircling tensioning member 58 in a proximal direction from second anchor 54 is crimpable retainer ring 98.
  • first anchor 54 when packed inside delivery catheter 114, first anchor 54 is in contact with a push rod 102.
  • push rod 102 passes from the proximal end of delivery catheter 114 (not depicted), to contact the proximal side of first anchor 54.
  • Delivery catheter 114 is configured to allow actuation of push rod 102 to push first anchor 54 out of delivery catheter 114.
  • push rod 102 is applied to the second anchor and when slightly advanced, only pushes out the first anchor.
  • the first anchor includes a projection that extends perpendicular to the catheter so that when the catheter is pulled back through cardiac muscle, the projection engages the surrounding tissue and pulls out the first anchor.
  • crimpable retainer ring 98 is optionally encircled by the jaws of crimper-cutter 108.
  • Delivery catheter 114 is configured to allow actuation of crimper- cutter 108, closing the jaws to crimp crimpable retainer ring 98 around tensioning member 58.
  • the jaws of crimper-cutter 108 are actuated to close, one or more optional blades inside crimper cutter 108 (not visible in the Figures) cut through a portion of tensioning member 58 that passes therebetween, proximally to crimpable retainer ring 98.
  • a transcatheter-deployed embodiment of the method of the present invention is optionally implemented by deploying device 112 in a heart 50 of a subject where an annuloplasty ring 80 has been previously deployed as depicted in Figures 9C to 9G.
  • the subject is optionally prepared in the usual way for catheterization, including the optional deployment of a transseptal cannula through the fossa ovalis (not depicted).
  • a piercing catheter 122 (optionally tip 126, below) is used to pierce a hole through mitral valve annulus 34, near the aortic-mitral curtain touching annuloplasty ring 80.
  • a guide wire 124 is passed through the hole in mitral valve annulus 34 into left ventricle 28 so that the tip of guide wire 124 is in proximity of a selected region of wall 68 of left ventricle 28, Figure 9C.
  • Delivery catheter 114 is guided along guide wire 124 into left ventricle 28 to contact wall 68.
  • Piercing tip 126 of delivery catheter 112 is used to pierce through wall 68 of left ventricle 28, Figure 9D.
  • one or both penetrations of the heart chamber walls in this and other embodiments is by an externally threaded catheter that is screwed into and through the wall.
  • Push rod 102 is optionally actuated to push first anchor 54 out from delivery catheter 114. Released form at least some constraints, first anchor 54 expands to an expanded conformation, optionally so that concave contact face 64 faces surface 66 of heart 50, Figure 9E.
  • Delivery catheter 114 and guide wire 124 are withdrawn from left ventricle 28, trailing tensioning member 58 that is secured to first anchor 54.
  • second anchor 56 is pushed out of delivery catheter 112 using crimper- cutter 108 to engage annuloplasty ring 80, Figure 9F.
  • anchor 56 is pulled out by tensioning member 58.
  • a holder (not shown, for example, a pliers-like jaw or a wire that is hooked onto the anchor and is coupled to the delivery tube, for example, outside the body) is used to prevent premature release of second anchor 56.
  • tensioning member 58 is drawn taut while the end of crimper-cutter 108 is pressed against crimpable retainer ring 98 and base 120 of second anchor 56.
  • the tension applied by tensioning member 58 is varied while viewing the magnitude of regurgitation into left atrium during ventricular systole with an imaging modality in the usual way: the tension is increased to decrease the distance between first anchor 54 and second anchor 56 as defined by tensioning member 58 and the tension is decreased to increase the distance between first anchor 54 and second anchor 56.
  • crimper-cutter 108 is activated to crimp crimpable retainer ring 98 around tensioning member 58, thereby defining the distance between first anchor 54 and second anchor 56 as well as cutting tensioning member 58, thereby defining the distance between first anchor 54 and second anchor 56 and also cutting through the apical portion 76 of tensioning member 58.
  • a delivery catheter such as 114 for deploying a device according to the teachings of the present invention may be configured to pass through the any suitable path through the vasculature of a subject.
  • a delivery catheter such as 114 is designed to access a left atrium 24 from a right atrium 12 transseptally. In some embodiments, a delivery catheter such as 114 is designed to access a right atrium 12 using a percutaneous antegrade approach.
  • a delivery catheter such as 114 is designed to access a right atrium 12 from the superior vena cava. In some embodiments, a delivery catheter such as 114 is designed to access a superior vena cava from a jugular vein (left or right, preferably right) or a subclavian vein (left or right, preferably right)
  • a delivery catheter such as 114 is designed to access a right atrium 12 from the inferior vena cava. In some embodiments, a delivery catheter such as 114 is designed to access an inferior vena cava from a femoral vein, for example a left or a right femoral vein. In an exemplary embodiment of the invention, a delivery catheter such as 114 is designed to access the left ventricle via the coronary sinus.
  • Figs 10A-11I illustrate a trans- coronary sinus approach which may use a catheter substantially as described in Figs. 9A-9G.
  • an additional element, a coronary sinus guide is provided, as shown in Figs. 10A- 10E.
  • the guide is used to assist the delivery catheter in exiting the coronary sinus at a desired angle and location to enter the left ventricle.
  • a guide may have an addition function of annuloplasty.
  • the guide is a standard annuloplasty ring, with hollow sections and/or a guide formed therein, as described below.
  • the guide is formed as a spring (e.g., a coil spring).
  • the guide is hollow except for a guiding section provided therein and which interferes in part or completely with a catheter inserted into the guide from passing through the guide past the guiding section and/or which guides any such inserted catheter to an aperture at the side of the guide.
  • FIG. 111 shows a schema of an exemplary procedure.
  • a delivery catheter 114 is shown riding on a guide wire 1018, entering a coronary sinus guide 1000 in the form of a tubular element 1102, exiting the guide at a medial location therealong (or more distally or more proximally, depending on desired anchor location) and laying a tensioning member 58 to a first, apical, anchor 54, with guide 1000 optionally serving as a second anchor.
  • guide 1000 includes both a distal anchoring section 1110, such as a ball and a proximal anchoring section 1112, such as a ball, as known for annuloplasty rings for the coronary sinus.
  • a funnel 1114 is provided to help guide catheter 114 and/or guidewire 1018 into guide 1000.
  • catheter 114 in this and/or other embodiments has an outer diameter of 1 mm, 2 mm, 3 mm, 4 mm, 5 mm or smaller, intermediate or larger diameters.
  • a trans-apical application tube has an outer diameter (e.g., at point of penetration into the heart) of less than 20 mm, 15 mm, 10 mm, 7 mm, 5 mm , 3 mm, 2 mm or intermediate diameters.
  • guide 1000 is small enough in diameter to not cause undue blockage of the coronary sinus, for example, having a diameter of 5.0 mm.
  • the diameter of the guide is decided by the need to cause a bending of more than 60, 70, 80 or even 90 degrees of catheter 114, and the limits of flexibility of such a catheter and/or contents thereof and/or ability of the guide to function as an annuloplasty ring, if desired.
  • the location of the exit along guide 1000 depends on the desired effect.
  • a plurality of exit points are provided, for example, for providing multiple anchoring locations at different sides of the mitral valve.
  • Such multiple anchoring locations an also be provided in accordance with other embodiments of the invention.
  • the locations are at different points along the annulus of the mitral valve.
  • the first anchor may be located, for example, at the middle of the posterior mitral annulus.
  • Figs. 10A-10E illustrate a guide 1000 for a trans-coronary sinus approach, in accordance with an exemplary embodiment of the invention, at various stages of use thereof. While typically not so, guide 1000 is illustrated as if transparent to make the inner workings clearer.
  • Fig. 10A shows a guide 1000, optionally having no moving parts and having the property that a guide wire once retracted therefrom will most easily follow a pathway out of a side of the guide, rather than an original axial pathway.
  • Guide 1000 includes a body having a hollow portion 1002 which communicates with an opening 1022 in a proximal side of guide 1000 and has a guiding section 1012 which leads to an aperture 1014 in the side of guide 1000.
  • a far section 1004 past guide 1012 may be, for example, solid (1016), sealed and hollow, or open to the distal side of guide 1000. In general, however, a catheter inserted through opening 1022 will not be able to reach the far section, due to blocking of guide 1012, for example.
  • Exemplary average diameters of guide 1000 are less than 20 mm, less than 15 mm, less than 10 mm, less than 5 mm or intermediate diameters. By average diameter is meant a maximum trans-axial dimension averaged over the parts of the device designed for being in the coronary sinus.
  • guide 1000 is designed to block less than 80%, 70%, 60%, 45%, 30%, 20% or intermediate percentages of the cross-section of an adult coronary sinus to blood flow.
  • guide 1000 is radially collapsible to assist in venous delivery thereof.
  • a guidewire channel 1006 does communicate between section 10022 and the distal side of guide 100, having a proximal opening 1008 and a distal opening 1010.
  • Fig. 10B shows a guidewire 1018 threaded through guidewire channel 1018.
  • guide wire 1018 has a bend 1020 at its tip.
  • Fig. 10C shows a situation where guide 1000 is not near the tip of the guidewire.
  • Guide 1000 will typically be delivered to the coronary sinus in this condition.
  • the guidewire is retracted out of guidewire channel 1006 (possibly retracted completely and reinserted into lumen 1022), where it is seen that bend 1020 would interfere with reinsertion of the guidewire into channel 1006.
  • channel 1006 is continuous with an inner wall of section 1002.
  • advancement of guidewire 1018 causes it to be guided by guiding section 1012 to exit through aperture 1014 at a desired orientation, position and/or direction into the heart.
  • Figs. 11A-11 I illustrate stages in a deployment of a device via a coronary sinus, using guide 1000, in accordance with an exemplary embodiment of the invention.
  • guidewire 1018 (or another guidewire) is brought through the venous system through a coronary sinus osteum 1104 and into a coronary sinus 1102.
  • guide 1000 is advanced along guidewire 1018 and into the coronary sinus, optionally using a guide catheter (not shown).
  • guide 1000 is in place and guide wire 1018 is partially retracted (See Fig. 10D).
  • guidewire 1018 is advanced and guided by guide 1000 into the cardiac wall, which it penetrates.
  • the guidewire is replaced before such guiding for a sharp- tipped guide wire.
  • catheter 114 is advanced along guidewire 1018 and has a sharp tip which provides such penetration ability.
  • correct orientation is provided by the location and angle of the hole in the "guide”.
  • the penetration from aperture 1014 is towards the left ventricle and through muscle, rather than fibrous material.
  • guide 1000 is pre-bent, so that when positioned in the coronary sinus it reaches a known shape and orientation relative to the heart.
  • delivery catheter 114 penetrates (and/or guidewire 1018 is advanced with or before catheter 114 to cause said penetration) the far wall of the left ventricle (or other desired far point).
  • a first anchor 54 is deployed and catheter 114 retracted, leaving tensioning member 58 in the left ventricle.
  • Fig. 11G the tension in tensioning member 58 is optionally adjusted.
  • tensioning member 58 is cut to size and locked in place and the guidewire may be withdrawn from the body.
  • guidewire 1018 serves as tensioning member 58.
  • Fig. 111 shows a schema of the complete exemplary procedure.
  • guide 1000 serves as a second anchor.
  • a bead or rod or other object, having a greatest dimension greater than that of aperture 1014 is advanced along tensioning member 58 and/or fixed thereto, to lock member 58 to guide 1000.
  • a second anchor is deployed through aperture 1014 and the guide 1000 is optionally removed (for example if the ring does not act as an annuloplasty ring).
  • guide 1000 includes multiple (e.g., 2, 3,
  • apertures 1014 and guiding sections 1012 to define multiple exit points, optionally at different orientations (e.g., circumferential positions and/or guide angles relative to axis).
  • the apertures and guides are provided at different axial locations and each guide blocks part (e.g.,
  • a guidewire when a guidewire is advanced, it can be made to engage a guide or go past the guide to a next guide.
  • the sizes of guide 1000 and catheter 114 are optionally selected so that catheter 114 can pass a guide and still be suitably guided by a next guide.
  • a second (and third if needed) device is now applied with same technique at different points as planned according to the shape of the heart.
  • Catheter approach when used for Ischemic MR (i) A leading guide wire is inserted through the femoral or jugular vein (or any other big vein). Under TEE guidance the wire with the device is advanced to the right atrium and through the atrial septum into the left atrium.
  • a leading guide wire is inserted through the femoral or jugular vein (or any other big vein). Under TEE guidance the wire with the Device is advanced to the right atrium and through the atrial septum into the left atrium.
  • a second (and third if needed) device is now applied with same technique in different LV points as planned according to the shape of the heart.
  • the distance between the coupled anchors is now gradually shortened along the tension members until the desired LV shape is achieved.
  • the device need not pass through the apex, for example, being 1 , 2, 3, 4 or intermediate or more centimeters from the apex. Similarly, the device may not pass through papillary muscles.
  • the device is provided as a temporary measure, for example, until surgery, as a prophylactic and/or until scar tissue is formed to stabilize the heart.
  • a device may be implanted soon after (e.g., less than or about 1 , 2 ,3 ,4 or 5 weeks) an event of cardiac ischemia which damages cardiac tissue.
  • tensioning element 58 is made degradable in such access.
  • tensioning member 58 is selected so that it applies tension only when the heart reaches certain geometries (e.g., end diastole).
  • tensioning member 58 includes elasticity which is selected to minimally interfere at a first length, apply some force at a second length and apply an even greater force at a third length. The greater force possibly being selected to be effectively or actually a limit on cardiac motion. In an exemplary embodiment of the invention, such temporally-partial partial tension, allows the cardiac tissue to work and remodel correctly.
  • first anchor 54 is optionally a substantially mesh material.
  • a potential advantage of such a first anchor is that the plurality of holes through the mesh provides a user freedom as to how to orient and where to position the first anchor and tensioning members, including optionally easily allowing securing of a plurality of tensioning members.
  • kits such as discussed above for devices 52, 82 and 92, are provided as a kit.
  • a kit comprises a first anchor.
  • a kit comprises a first anchor and a second anchor.
  • a kit comprises a first anchor, a second anchor and tensioning member or members.
  • a kit is provided without a tensioning member.
  • a kit is provided with two (or more) tensioning members, precut to approximately the appropriate length.
  • a single long strand is provided, for example on a spool, and the desired number and lengths of tensioning members are cut from the provided strand.
  • a kit comprises an annuloplasty ring.
  • a tensioning member is provided with a needle at one end.
  • a tensioning member is provided with two needles, one at each end, for example for use in embodiments similar to device 52.
  • first anchor 54 is fashioned ad hoc from surgical felt.
  • a first anchor of felt or similar material is provided preformed, for example as a part of a kit.
  • tensioning members 58 pass through a left ventricle 28 care is taken to avoid penetrating papillary muscles 44 so as not to affect the functioning thereof.
  • a tensioning member passes through a papillary muscle or a portion of a papillary muscle.
  • a device for applying pressure to a portion of a heart is deployed together with or without an annuloplasty ring such as 80.
  • an annuloplasty ring such as 80.
  • whether or not an annuloplasty ring is deployed with a device for applying pressure to a portion of a heart is determined by a treating physician.
  • a device for applying pressure to a portion of a heart is deployed in a heart where an implantable prosthesis such as an annuloplasty ring or a prosthetic heart valve has previously been deployed, for example a few weeks, a few months or even a few years previously.
  • a treating physician determines, for example, that there is insufficient mitral valve leaflet coaptation despite the presence of an annuloplasty ring or an artificial heart valve and therefore decides to deploy a device for applying pressure to a portion of the heart.
  • the teachings herein are applied in conjunction with mitral valve replacement procedures, for example, certain cases of rheumatic heart disease, especially in cases where preservation of the subvalvular apparatus is not possible.

Abstract

La présente invention concerne un appareil de traitement d'un cœur, qui comprend un tube de délivrance dimensionné et adapté pour être inséré dans un corps; une pointe affûtée adaptée pour être poussée à travers le muscle cardiaque; un élément de tension allongé; et au moins une ancre sur ledit élément de tension allongé, adaptée pour coupler ledit élément de tension allongé au tissu du muscle cardiaque, ledit tube de délivrance entourant un ou les deux desdits éléments et ladite au moins une ancre.
EP08864599A 2007-12-20 2008-12-21 Procédés et dispositifs de traitement d'un c ur Ceased EP2231028A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1547107P 2007-12-20 2007-12-20
US7514308P 2008-06-24 2008-06-24
PCT/IL2008/001645 WO2009081396A2 (fr) 2007-12-20 2008-12-21 Procédés et dispositifs de traitement d'un cœur

Publications (1)

Publication Number Publication Date
EP2231028A2 true EP2231028A2 (fr) 2010-09-29

Family

ID=40512529

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08864599A Ceased EP2231028A2 (fr) 2007-12-20 2008-12-21 Procédés et dispositifs de traitement d'un c ur

Country Status (2)

Country Link
EP (1) EP2231028A2 (fr)
WO (1) WO2009081396A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019013994A1 (fr) * 2017-07-10 2019-01-17 4Tech Inc. Ancrages de tissu dotés d'éléments de support de charge

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE329531T1 (de) 1999-07-02 2006-07-15 Quickpass Inc Chirurgisches nähgerät
US8197497B2 (en) 2005-06-20 2012-06-12 Medtronic Vascular, Inc. Method and apparatus for applying a knot to a suture
JP5411125B2 (ja) 2007-03-29 2014-02-12 ノーブルズ メディカル テクノロジーズ、インコーポレイテッド 卵円孔開存を閉鎖するための縫合装置、及びシステム
WO2010070649A1 (fr) 2008-12-21 2010-06-24 Mor Research Applications Ltd. Corps allongé pour son déploiement dans un sinus coronaire
US8771296B2 (en) 2008-05-09 2014-07-08 Nobles Medical Technologies Inc. Suturing devices and methods for suturing an anatomic valve
EP2528511A4 (fr) * 2010-01-29 2014-08-27 Med Venture Investments Llc Procédés et appareils pour suture d'ouvertures cardiaques
EP2697721B1 (fr) 2011-04-15 2019-09-18 Heartstitch, Inc. Dispositifs de suture d'une valvule anatomique
EP3395298A1 (fr) 2011-06-27 2018-10-31 University of Maryland, Baltimore Dispositif de réparation de valvule mitrale transapicale
US10076414B2 (en) 2012-02-13 2018-09-18 Mitraspan, Inc. Method and apparatus for repairing a mitral valve
US9011531B2 (en) * 2012-02-13 2015-04-21 Mitraspan, Inc. Method and apparatus for repairing a mitral valve
US9706988B2 (en) 2012-05-11 2017-07-18 Heartstitch, Inc. Suturing devices and methods for suturing an anatomic structure
EP3473189A1 (fr) 2013-07-02 2019-04-24 Med-venture Investments, LLC Dispositifs de suture d'une structure anatomique
WO2015085145A1 (fr) 2013-12-06 2015-06-11 Med-Venture Investments, Llc Procédés et appareils de suture
US9681864B1 (en) 2014-01-03 2017-06-20 Harpoon Medical, Inc. Method and apparatus for transapical procedures on a mitral valve
US10178993B2 (en) 2014-07-11 2019-01-15 Cardio Medical Solutions, Inc. Device and method for assisting end-to-side anastomosis
JP6717820B2 (ja) 2014-12-02 2020-07-08 ４テック インコーポレイテッド 偏心組織アンカー
US10779933B2 (en) 2014-12-22 2020-09-22 Syntach Ag Device, system and method for anchoring to muscle tissue
WO2017059426A1 (fr) 2015-10-02 2017-04-06 Harpoon Medical, Inc. Appareil et procédés d'ancrage distal pour réparation de valvule mitrale
EP3364917A1 (fr) * 2015-10-21 2018-08-29 Coremedic AG Appareil médical et procédé pour réparation de valvule cardiaque
US10583007B2 (en) 2015-12-02 2020-03-10 Edwards Lifesciences Corporation Suture deployment of prosthetic heart valve
US10687801B2 (en) 2016-04-11 2020-06-23 Nobles Medical Technologies Ii, Inc. Suture spools for tissue suturing device
US10624743B2 (en) 2016-04-22 2020-04-21 Edwards Lifesciences Corporation Beating-heart mitral valve chordae replacement
US10765515B2 (en) 2017-04-06 2020-09-08 University Of Maryland, Baltimore Distal anchor apparatus and methods for mitral valve repair
WO2018236766A1 (fr) 2017-06-19 2018-12-27 Heartstitch, Inc. Systèmes et procédés de suture destinés à suturer un tissu corporel
CA3065223A1 (fr) 2017-06-19 2018-12-27 Harpoon Medical, Inc. Procede et appareil pour interventions cardiaques
WO2018236822A1 (fr) 2017-06-19 2018-12-27 Heartstitch, Inc. Dispositifs de suture et procédés de suture d'une ouverture dans l'apex du cœur
WO2019035095A1 (fr) 2017-08-18 2019-02-21 Nobles Medical Technologies Ii, Inc. Appareil pour pratiquer un nœud sur une suture
WO2019055527A1 (fr) * 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research Procédés et dispositifs de fixation de dispositifs épicardiques
CA3076928A1 (fr) 2017-10-24 2019-05-02 University Of Maryland, Baltimore Procede et appareil pour interventions cardiaques
US11219772B2 (en) 2017-10-25 2022-01-11 Mayo Foundation For Medical Education And Research Devices and Methods for cardiac pacing and resynchrontzation
WO2019195860A2 (fr) 2018-04-04 2019-10-10 Vdyne, Llc Dispositifs et procédés d'ancrage d'une valvule cardiaque transcathéter
US11517435B2 (en) 2018-05-04 2022-12-06 Edwards Lifesciences Corporation Ring-based prosthetic cardiac valve
US10321995B1 (en) 2018-09-20 2019-06-18 Vdyne, Llc Orthogonally delivered transcatheter heart valve replacement
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
AU2020231221A1 (en) 2019-03-05 2021-09-23 Vdyne, Inc. Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
EP3965701A4 (fr) 2019-05-04 2023-02-15 Vdyne, Inc. Dispositif cinch et procédé de déploiement d'une valvule cardiaque prothétique à pose latérale dans un anneau natif
CA3152042A1 (fr) 2019-08-20 2021-02-25 Vdyne, Inc. Dispositifs d'administration et de recuperation et procedes pour valvules prothetiques transcatheter a pose laterale
AU2020337235A1 (en) 2019-08-26 2022-03-24 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery
IT202000012562A1 (it) 2020-05-27 2021-11-27 Milano Politecnico Dispositivo e assieme per riparare una valvola cardiaca
WO2023003700A1 (fr) * 2021-07-20 2023-01-26 Edwards Lifesciences Corporation Cordages artificiels
US11357629B1 (en) * 2021-10-25 2022-06-14 Rainbow Medical Ltd. Diastolic heart failure treatment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083742A1 (en) * 2000-02-02 2003-05-01 Paul A. Spence Heart valve repair apparatus and methods
US20050228422A1 (en) * 2002-11-26 2005-10-13 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961440A (en) * 1997-01-02 1999-10-05 Myocor, Inc. Heart wall tension reduction apparatus and method
US6260552B1 (en) * 1998-07-29 2001-07-17 Myocor, Inc. Transventricular implant tools and devices
US20060079736A1 (en) * 2004-10-13 2006-04-13 Sing-Fatt Chin Method and device for percutaneous left ventricular reconstruction
US20070203391A1 (en) * 2006-02-24 2007-08-30 Medtronic Vascular, Inc. System for Treating Mitral Valve Regurgitation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083742A1 (en) * 2000-02-02 2003-05-01 Paul A. Spence Heart valve repair apparatus and methods
US20050228422A1 (en) * 2002-11-26 2005-10-13 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019013994A1 (fr) * 2017-07-10 2019-01-17 4Tech Inc. Ancrages de tissu dotés d'éléments de support de charge

Also Published As

Publication number Publication date
WO2009081396A2 (fr) 2009-07-02
WO2009081396A3 (fr) 2009-08-20

Similar Documents

Publication Publication Date Title
US9131928B2 (en) Elongated body for deployment in a heart
WO2009081396A2 (fr) Procédés et dispositifs de traitement d'un cœur
US11672659B2 (en) Device, system, and method for transcatheter treatment of valvular regurgitation
AU2021236494B2 (en) Artificial chordae tendineae repair devices and delivery thereof
JP7004765B2 (ja) インプラントを固定するためのシステムおよび方法
US20210393404A1 (en) Methods, systems and devices for cardiac valve repair
US20230404757A1 (en) Device, system, and method for transcatheter treatment of valvular regurgitation
US20230147741A1 (en) Device, system, and method for transcatheter treatment of valvular regurgitation
US10667911B2 (en) Methods, systems and devices for cardiac valve repair
US9060858B2 (en) Methods, systems and devices for cardiac valve repair
US7316706B2 (en) Tensioning device, system, and method for treating mitral valve regurgitation
US8470028B2 (en) Methods, systems and devices for cardiac valve repair
US20100298929A1 (en) Methods, systems and devices for cardiac valve repair
US20060161040A1 (en) Methods and devices for improving cardiac function in hearts
US20240033083A1 (en) Device, system, and method for transcatheter treatment of valvular regurgitation
EP3120811A2 (fr) Procédés, systèmes et dispositifs de réparation de valvule cardiaque
WO2020236417A1 (fr) Ancrage expansible pour dispositifs de réparation de valvules cardiaques
US20230414825A1 (en) Suture encapsulation processes and systems

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100719

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20111013

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20170223